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ABSTRACT 
SEIZURE AND BEHAVIORAL PHENOTYPING OF THE SCN1A MOUSE MODEL  
OF GENETIC EPILEPSY WITH FEBRILE SEIZURES PLUS            
by  
ASHLEY W. HELVIG 
Genetic epilepsy with febrile seizures plus (GEFS+) is associated with a wide 
range of neurological dysfunction caused in part by limited function in voltage-gated 
sodium channels (Escayg & Goldin, 2010; Gambardella & Marini, 2009; Mulley et al., 
2005).  The seizure and behavioral phenotypes, as well as use of non-pharmacologic 
agents as neuroprotectants in GEFS+, are not well-understood.  An experimental design 
used an animal model of GEFS+ to 1. explore the effects of stress on seizure phenotype, 
2. examine behavioral phenotypes, and 3. study the effects of an omega 3 fatty acid on 
abnormal behaviors noted in the various paradigms.     
 This study used C57BL/6J mice with the R1648H missense mutation on the 
Scn1a gene (engineered in the Escayg lab) (Martin, M. S. et al., 2010).  The three specific 
aims used separate groups of animals for experimentation, and all paradigms were 
performed under strict laboratory conditions. 
 Data were analyzed using either an independent t-tests, two-way ANOVA or 
repeated measures two-way ANOVA.  Results showed that stress worsens seizure 
 v 
 
phenotype in both the Scn1aR1648H (RH) mutants and wild-type (WT) group with the RH 
mutants more severely impacted.  In addition, there was clear and consistent evidence for 
hyperactive locomotor behavior.  Lastly, no evidence was found for use of 
docosahexaenoic acid (DHA, an omega 3 fatty acid) as a neuroprotectant for 
hyperactivity (DHA was given subcutaneously for two weeks starting at weaning).  
Outcomes from this study implicate that stress worsens the seizure phenotype in 
animals with Scn1aR1648H.  This study is also the first to report hyperactive locomotor 
behavior in animals with Scn1aR1648H.  Results from this study may broaden beyond 
GEFS+ in that we may also be able to apply the findings to other disorders with SCN1A 
dysfunction.  In addition, it may be that genetic variants affecting SCN1A, but not 
necessarily in epilepsy, may contribute to hyperactivity.  This could mean that SCN1A is 
a candidate gene for hyperactivity.  The main goal of nursing care is to reduce and 
prevent disease morbidity, and knowledge gained from the current study will guide 
clinical nursing practice, such as targeted behavioral assessment and education, as well as 
nursing research focusing on children with this genetic disorder.   
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CHAPTER I 
INTRODUCTION 
 Chapter one consists of the overall significance of the problem of epilepsy, 
specifically genetic epilepsy with febrile seizures plus (GEFS+), the impact of stress on 
seizure activity as well as behavior (i.e., anxiety, depression or social stress), and 
explores omega 3 polyunsaturated fatty acids (PUFA’s) as a neuroprotectant against 
undesirable neurological outcomes.  Descriptions of the specific aims and hypotheses are 
also presented.  Lastly, an explanation of the physiological theory of stress and epilepsy 
that was used to guide this study is given.  We hypothesized that stress will negatively 
impact seizure and behavioral phenotypes, and that consumption of omega 3 
polyunsaturated fatty acids will provide neuroprotection against neurological deficits.  
This study uses an animal model consisting of mice with the R1648H (RH) missense 
mutation on the Scn1a gene which recapitulates the human condition of GEFS+ (Martin, 
M. S. et al., 2010).       
Significance of the Problem 
Epilepsy  
 Epilepsy is described as a wide spectrum of disorders that involves seizure 
activity (http://www.epilepsyfoundation.org/).  It usually manifests early in life or in later 
adulthood but can begin in adolescence or middle adulthood as well.  Approximately 3 
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million people in the United States are affected by epilepsy (http://www.epilepsy 
foundation.org/), and compared to the general population, these individuals have a 
potential 2 to 3 times higher rate of mortality (Terra, Arida, Rabello, Cavalheiro, & 
Scorza, 2011).  Even though 60% of cases are due to an injury or other disease processes, 
40% of cases have an unknown origin (Escayg & Goldin, 2010).  Children who have 
simple febrile seizures (seizure activity initiated by a fever) usually stop having seizures 
by the age of six (http://www.ninds.nih.gov/disorders/febrile_ seizures/febrile_ 
seizures.htm).  The Epilepsy Foundation reports that children (less than age ten) are more 
likely to have generalized seizures whereas partial seizures are more common after age 
ten.   
Abnormal electrical activity in the central nervous system initiates the seizure 
activity and can produce a wide range of neurological activity from absence seizures to 
generalized tonic-clonic seizures (http://www.epilepsyfoundation.org/).  Absence 
seizures are considered to be benign, although they can affect learning and memory, and 
are characterized by staring.  Myoclonic seizure activity consists of sudden jerks of 
muscles, typically bilaterally.  Partial seizures occur when only a specific area of the 
brain is impacted by hyperexcitability and can lead to various types of movements or 
sensations depending on the location in the brain.  Generalized seizures impacts both 
sides of the brain and can lead to generalized tonic-clonic seizures that consist of 
stiffening of muscles and then jerking movements of the extremities and face.  Febrile 
seizures can produce tonic-clonic seizures and can be frightening to parents; however, 
these are usually benign and do not persist past age six (http://www.epilepsy 
foundation.org/).  Certain epileptic disorders can be extremely severe such as Dravet 
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syndrome.  This is a disorder that occurs in the first months of life and causes 
developmental delay, mental retardation, ataxia, and decreased life expectancy (Escayg & 
Goldin, 2010).  
In addition to physiological effects, many psychological effects have been linked 
with seizure disorders.  Depression has been found in a large number of people with 
epilepsy (de Souza & Salgado, 2006; Ottman et al., 2011).  Many people with epilepsy 
and co-morbid depression are taking multiple anti-epileptic medications, have limitations 
set upon them such as not being able to drive, and have feelings of isolation (Lu & 
Elliott, 2011).  Anxiety is also a problem for persons with epilepsy (de Oliveira et al., 
2011; Ottman et al., 2011).  Many times seizures are not well-controlled, thus the 
unknown possibility of seizure activity is anxiety-producing.  Also, the concern if a 
seizure happens during work or school and the worry of how other people will react are 
important factors for patients with epilepsy.  Suicidal thoughts have also been associated 
with people who have seizure disorders (de Oliveira et al., 2011).   
Physiological and Emotional Stress 
 During the stress response, there are 2 basic physiological responses.  One 
response involves the short acting sympathetic system acting to increase epinephrine and 
norepinephrine which increase heart rate, mental acuity, and blood pressure.  The second 
response involves the Hypothalamic-Pituitary-Adrenal (HPA) axis.  The hypothalamus 
secretes corticotrophin releasing factor (CRF) which stimulates the pituitary to release 
adrenocorticotropic hormone (ACTH) which in turn stimulates corticosterone release 
from the adrenal glands (Brunson, Avishai-Eliner, & Baram, 2002; de Kloet, Joels, & 
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Holsboer, 2005).  Corticosterone is responsible for the release of glucocorticoids and 
mineralocorticoids.  The stressful event is subjective, and the appraisal center of the brain 
consists of the limbic system.  It is important to remember that stress can be a 
physiological stressor such as a wound infection or seizure, or it can be a psychological 
stressor which is interpreted individually.   
Stress and Epilepsy 
Multiple studies have attempted to examine the correlation between stress and 
epilepsy.  However it is difficult to study stress in epilepsy because it is multi-factoral 
(Lai & Trimble, 1997; Swinkels et al., 1998).  For example, it is difficult to quantify 
stress, and stress itself can lead to other issues such as depression, sleep problems or 
unhealthy habits (drinking alcohol or smoking).  Additionally, the seizure itself is a 
stressor (Lai & Trimble, 1997). 
In general, animal studies as well as human studies report that seizure activity 
induces the stress response (increase in stress hormones), and stress can negatively 
impact seizure activity; however, there are a few studies that report anti-convulsive 
properties of stress (Abel & Berman, 1993; Sawyer & Escayg, 2010).  Also, researchers 
have examined physiological responses to stress in people with epilepsy and found 
alterations in the HPA axis (Zobel et al., 2004).  These findings are also validated in 
animal studies (Ehlers et al., 1983; Mazarati et al., 2009). 
Multiple studies have examined the prevalence of behavioral outcomes to stress 
such as anxiety and depression in humans as well as in animal models of epilepsy with 
varying outcomes.  Lu and Elliott (2011) examined mental health in people with epilepsy 
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and reported that the seizure frequency itself was not correlated with poor mental health, 
but rather the activity limitations that having seizures created.  These findings add to the 
body of knowledge that studying stress and epilepsy in humans is complex.  Animal 
models of stress and epilepsy may help to provide better insight into the outcomes and 
mechanisms through which stress impacts epilepsy since most variables can be 
controlled.   
Basically there are multiple models of stress and epilepsy that have reported 
multiple outcomes (Sawyer & Escayg, 2010).  Therefore it is important to examine this 
particular genotype because it is a model of a human condition.  No one has specifically 
looked at the variables in the current study. 
Epilepsy and the Co-Morbid Condition of ADHD 
 The association between epilepsy and ADHD has long been established with 
reports of significantly higher levels of ADHD in children with epilepsy compared to 
those without epilepsy (Cohen et al., 2012; McDermott, Mani, & Krishnawami, 1995; 
Russ, Larson, & Halfon, 2012).   Similar findings are reported in adults with epilepsy 
(Ottman et al., 2011).  Despite the growing body of knowledge of epilepsy and symptoms 
of ADHD, there is little research regarding the specific disorder of GEFS+ and 
hyperactive behavior.  Case reports (Grant & Vazquez, 2005) and even larger studies 
(Brunklaus, Dorris, & Zuberi, 2011) indicate a possible association of various symptoms 
of ADHD in persons with GEFS+, but these are typically reported in the context of the 
most severe cases of GEFS+.  This is a gap in the literature that will be addressed by the 
current study.  
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Significance of ADHD.  
Hyperactive behavior is generally characterized in the diagnosis of a combined 
deficit of attention and hyperactivity as in attention-deficit hyperactivity disorder or 
ADHD in humans.  Attention-deficit hyperactivity disorder is increasing in incidence 
(CDC, 2010), though it is not understood if this is due to the improved ability to diagnose 
ADHD or if new cases are actually increasing.  In the United States, approximately 8% of 
children ages 3-17 were reported to have ADHD in 2008 (Bloom, Cohen, & Freeman, 
2009).  Poorer school performance (Diamantopoulou, Rydell, Thorell, & Bohlin, 2007), 
lower IQ scores and increased enrollment in special education (van Baar, Vermaas, 
Knots, de Kleine, & Soons, 2009), increased drug addiction (Falck, Wang, & Carlson, 
2008) as well as higher levels of antisocial and criminal behavior (Langley, K. et al., 
2010) are associated with ADHD.  More than $50 billion annually can be attributed to 
costs associated with ADHD; for example, medication and medical costs, special 
education, juvenile justice, and lost parent work days (Pelham, Foster, & Robb, 2007).  
Attention deficit hyperactivity disorder not only impacts the cognitive and social 
functioning of the child, it is a growing problem impacting society in many aspects.  
 Genetics and ADHD.   
Although environmental factors play a role in ADHD such as maternal smoking 
(Langley, Holmans, Van den Bree, & Thapar, 2007; Milberger, Biederman, Faraone, 
Chen, & Jones, 1996) and maternal alcohol consumption (Knopik et al., 2005), a genetic 
link to ADHD is becoming more apparent (Gilby, Thorne, Patey, & McIntyre, 2007; 
Ross, 2012).  As is the case with many physiological and psychological disorders, both 
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genetics and environment probably work together in various ways to impact hyperactive 
behavior.  This animal model of a sodium channel mutation could possibly provide 
insight into another genetic link to hyperactive behavior. 
Treatment Modalities for Epilepsy 
 Treatment for epilepsy primarily consists of pharmacological agents such as 
antiepileptics (i.e., 7henobarbital, phenytoin and valproic acid) or benzodiazepines (i.e., 
clonazepam and lorazepam) (http://www.epilepsyfoundation.org/; Karch, 2012); 
however, some people with seizures refractory to medications use alternate treatment 
methods.  Approximately 50% of people with epilepsy have complete seizure control for 
long periods of time, and 20% have very good seizure control with only occasional 
seizures; however, 30% of people have intractable seizures (http://www.epilepsy 
foundation.org/).  For the 30% of patients with seizures refractory to medications, some 
choose to undergo surgery to remove the seizure-producing area of the brain (mainly 
performed in adults).  
A dietary treatment used mainly in children is the ketogenic diet which uses 
stored fat for energy (80% of the diet is fat).  Some patients use vagus nerve stimulation 
in which an electrode is implanted to send bursts of electrical activity via the vagus nerve 
into the brain (http://www.epilepsyfoundation.org/).  It is important to note that all of 
these methods are treatments for epilepsy, and that there are no treatments to date that 
provide neuroprotection against seizure activity (prevention of seizure activity occurring 
in the first place). 
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Omega 3 PUFA’s and the Brain 
Omega 3 PUFA’s are essential fatty acids meaning they are found everywhere in 
the body, are essential in cell functioning (Holman, 1998), and because humans are not 
able to synthesize omega 3 PUFA’s, the body’s supply comes from consumption 
(Niemoller, Stark, & Bazan, 2009; Schuchardt, Huss, Strauss-Grabo, & Hahn, 2009).   
While there are multiple n-3 fatty acids in the body, the main omega 3 fatty acids are 
docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and alpha linolenic acid 
(ALA).  Both DHA and EPA are mainly found in animal sources and ALA is found 
mainly in non-animal sources (Taha, Burnham, & Auvin, 2010).  One of the benefits of 
consumption of omega 3 PUFA’s is that there rarely are side effects (Taha et al., 2010).   
DHA is the only fatty acid concentrated in the brain (Bazan, 2007).  In addition, 
the phospholipid bilayer of neurons contains DHA most abundantly compared to other 
omega 3 fatty acids (Niemoller et al., 2009).  And while the phospholipid layer of 
neuronal membranes are reported to have a large quantity of DHA during the postnatal 
period (Bazan, Musto, & Knott, 2011), Yavin (2006) states that DHA increases during 
different periods of fetal brain growth, emphasizing the importance of DHA in the 
development of the CNS.  The building of critical brain circuits during the pre-natal as 
well as post-natal developmental period relies on the supply of DHA (Bazan, et al., 
2011).  Additionally, it is understood that DHA specifically interacts with ion channels 
(Taha et al., 2010).  
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Purpose 
The purpose of this study was to build upon animal models of genetic epilepsy 
with febrile seizures plus (GEFS+) by examining the stress response in mice with the 
R1648H (RH) missense mutation in the Scn1a gene as well as the ability of omega 3 fatty 
acids to protect against abnormal neurological activity.   
Significance of the Study 
To accomplish this, we will expand upon previous research that has linked stress 
and seizure activity as well as research focusing on the neuroprotective effects of omega 
3 fatty acids.  Epilepsy affects approximately 3 million people in the United States with 
an economic impact of over $17 billion per year (http://www.epilepsyfoundation.org/).  
Unlike simple febrile seizures that typically do not occur in children greater than six 
years of age, individuals with GEFS+ often experience febrile seizures into their teenage 
years and develop epilepsy in adulthood (Burgess, 2005).  GEFS+ is an inherited disorder 
with a wide variety of symptom severity and age of onset (Escayg & Goldin, 2010) and 
may be associated with learning deficits, behavioral problems, neuropsychiatric disorders 
and developmental delay (Mahoney et al., 2009).  Hyperactive behavior has also been 
reported in children with epileptic disorders (McDermott et al., 1995; Russ et al., 2012) 
as well as being associated specifically with Dravet syndrome (a severe form of GEFS+) 
(Brunklaus et al., 2011).  In addition, physiological and emotional stress is a concern for 
people with epilepsy, and human studies have reported stress increases seizure frequency 
and severity (Bosnjak, Vukovic-Bobic, & Mejaski-Bosnjak, 2002; Swinkels et al., 1998).  
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Multiple pharmacologic therapies are available for the treatment for epilepsy and 
co-morbid conditions such as hyperactivity; however, some people continue to have 
deficits that are refractory to medications or experience untoward side effects.  Because 
of the reduced efficacy of medications in some people, it is important to examine the 
impact of non-pharmacologic therapies for neurologic deficits.  Omega 3 polyunsaturated 
fatty acids (PUFA’s) have been studied for many years as protection for or treatment 
against various disease processes; however, its use in neurologic disorders is still being 
uncovered.  The lack of consistent data regarding the impact of stress in epilepsy, 
specifically in GEFS+, and non-pharmacologic treatment of neurological sequelae 
undermines the assessment and treatment of patients with epilepsy and emphasizes the 
need to study these areas.    
Animal models of human diseases provide unique opportunities to study 
unexplored phenomenon.  Animals used in the current study were generated by knock-in 
of the human SCN1A R1648H missense mutation into the mouse Scn1a gene (Martin et 
al., 2010); therefore, this model recapitulates the human condition of GEFS+.  
Additionally, the mouse strain C57BL/6J is a good animal for behavioral testing (Muller, 
Grticke, Bankstahl, & Lscher, 2009).  Using an animal model allows for enhanced 
control of extraneous variables, co-morbidities and experimental conditions.  Animal 
models of human diseases are valuable when not much is known about a condition, 
allowing researchers to explore potentially unrecognized problems.   
 The specific aims of the study were to:  
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1. Define the picrotoxin-induced seizure phenotype of unrestrained as well as restrained 
(stressed) mice with the SCN1A R1648H missense mutation (RH) compared to wild-type 
(WT) mice (restrained and unrestrained)  
2. Define the behavioral response to a number of behavioral paradigms [Open field 
(anxiety and locomotion), forced swim test (depression), novel cage (response to 
novelty), predator odor (anxiety), and social interaction (social stress)] in the RH mice 
compared to WT mice  
3. Determine the neuroprotective effects of subcutaneous injections of docosahexaenoic 
acid (an omega 3 PUFA) on hyperactive behavior in RH mice.  
Providing evidence of these responses in genetically altered mice that recapitulate 
a human condition will help to expand knowledge of the spectrum of the phenotype in 
these mice and ultimately in humans.  Knowledge gained by examining omega 3 PUFA’s 
as a neuroprotectant will provide evidence for use of this non-pharmacologic therapy as a 
treatment for neurological morbidity.  Nurses care for patients with epilepsy in multiple 
settings such as hospitals, out-patient clinics, medical offices, and public health arenas.  
Additionally, nurses have the prime opportunity to monitor and educate patients with 
epilepsy (or familial history) regarding the negative impact of stress as well as non-
pharmacologic therapies for prevention or treatment of the patient with GEFS+. 
Hypotheses 
 The following hypotheses were proposed for this study:   
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1. H1: RH mice will have increased frequency and duration as well as severity of 
picrotoxin-induced seizure activity compared to WT mice,   
2. H2: Restraint stress will increase the frequency and duration as well as worsen the 
severity of picrotoxin-induced seizure activity in RH mice and WT mice 
compared to controls (RH and WT unrestrained mice),  
3. H3: The phenotypic behavioral traits in this model of GEFS+ will parallel those 
traits seen in epileptic humans  
4. H4: Administration of omega 3 PUFA’s to the RH mice will lead to a reduction in 
perturbed behavioral traits 
Theoretical Framework 
Many researchers have examined the effects of stress in epilepsy; however, no 
one has specifically described the impact of stress on the seizure phenotype in animals (or 
humans) with the Scn1a R1648H mutation.  Nor has anyone described a range of 
behavioral characteristics of this mutation.  Additionally, no one has examined the use of 
omega 3 PUFA’s to protect against neurological outcomes (specifically hyperactive 
behavior) in animals with this genetic mutation.  This study will fill the gaps in these 
areas.  We have developed a simplistic model of stress and epilepsy (see Figures 1 and 2).  
The first model represents specific aim 1 in which the first aspect is the condition.  The 
condition is the expression of the SCN1A R1648H mutation.  As described earlier, this 
mutation is found in families exhibiting, albeit with varying phenotypes, GEFS+.  
Approximately 10% of GEFS+ is due to SCN1A mutations (Gambardella & Marini, 
2009), and unfortunately the other 90% have unexplained symptomatology.  In general, it 
is reported that people with seizure disorders have higher levels of stress (Lai & Trimble, 
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1997).  Additionally, stress is considered one of the most frequent triggers of seizure 
activity, although some animal models demonstrate conflicting results (Abel & Berman, 
1993; Forcelli, Orefice, & Heinrichs, 2007).  The next piece of the first model is the 
insult.  The insult is a stressor which in the case of this study is the use of restraint stress.  
Restraint stress has been found to induce activation in the pre-frontal cortex in certain 
mouse strains (O’Mahony, Sweeney, Daly, Dinan, & Cryan, 2010).  Following the insult, 
we assessed the outcome which is the specific seizure phenotype.  Stress causes a cascade 
of neurohormones which triggers the release of glucocorticoids and mineralocorticoids 
(de Kloet et al., 2005; Mora, Segovia, del Arco, de Blas, & Garrido, 2012).  Brunson and 
colleagues (2002) state, “glucocorticoids modulate the expression and release of a 
number of neurotransmitters and neuromodulators” (p. 187).  Additionally, researchers 
have noted that corticotropin releasing factor has pro-convulsive properties (Ehlers et al., 
1983).  Therefore, we postulate that the stress the RH mice will encounter will exacerbate 
their seizure response.  
 In the second model (see Figure 2), representing specific aim 2, the stressor is the 
precipitating event.  This stressor could be multiple types of stressors; however, for this 
study, the stressors come in the form of novel environments, introduction to strangers or 
predator odor, or being forced to swim (Bailey & Crawley, 2009; Holmes, 2003).  For 
this particular aim of the study, we are not looking at potential seizure activity but rather 
the behavioral response to a stressor, because not every stressor in a human triggers a 
seizure.  The animal (with the RH mutation) encounters the stressor, and then the 
behavioral outcome is noted (which is the last piece of the model).  Previous research 
suggests that humans with epilepsy (as well as animals) have higher levels of anxiety 
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(Ottman et al., 2011).  Many human studies have also reported higher levels of 
depression in persons with epilepsy (de Souza & Salgado, 2006; Ottman et al., 2011).  
Therefore we infer that these mice will also exhibit signs of anxiety and depression.  
Social interaction is also of importance and is considered an indicator of quality of life 
(Heinrichs & Bromfield, 2008).  We anticipated that these mice would have altered social 
interaction in that they would also have avoidance behaviors.  
The last aspect of the model (representing specific aim 3) is the intervening step 
of the omega 3 PUFA’s.  As depicted in the model, these PUFA’s were given from 
weaning for 2 weeks.  It was speculated that these omega 3’s would alter the path of the 
model in that the insult would have little to no impact on the outcome.  There are studies 
that have examined the neuroprotective effects of omega 3 PUFA’s against symptoms of 
ADHD (i.e., hyperactivity); however the results are inconsistent, and the study 
methodology and subjects appear heterogeneous.  
 Although there is evidence of the impact of stress in epilepsy, there is a lack of 
understanding of the behavioral, as well as seizure response to stress in this particular 
sodium channel mutation.  Additionally, there are no studies using omega 3 PUFA’s as 
treatment against hyperactive behavior in an animal model of GEFS+.  This study 
increased the scientific evidence in all of these areas.  
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Figure 1.  Theory of Stress and Epilepsy (Part A) 
Condition          Insult               Seizure Outcomes 
  
Scn1a R1648H mutation             Stressor (restraint stress)             Shorter latency to seizure 
               More severe seizure 
        Longer duration of seizure 
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Figure 2.  Theory of Stress and Epilepsy (Part B) 
Stressor                                   Condition           Behavioral Outcomes 
                                                   Scn1a R1648H mutation  
Novel Environment               * Anxiety : Altered 
grooming behavior, 
decreased rearing 
behavior, altered 
burrowing behavior, 
increased 
staring/immobility 
Forced Swim test                 *Depression: Longer 
periods of 
immobility  
Social interaction test                 *Anxiety : Less              
interaction  
Predator Odor test      *Anxiety: Decreased rearing     
                Increased immobility 
Open Field          *Anxiety: Decreased 
time in center of field, 
increased time spent 
in perimeter, 
increased           
distance traveled  
    
  
Omega 3 change: Locomotion        
back to level of controls in 
open field paradigm   
      INTERVENTION: OMEGA 3 PUFA INJECTIONS SUBCUTANEOUSLY FOR 2 
WEEKS STARTING AT WEANING 
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This study contributed to the scientific knowledge in the area of seizure and 
behavioral phenotypes in an animal model recapitulating the human condition of GEFS+.   
In addition, the use of omega 3 PUFA’s as a treatment for neurological sequelae in this 
animal model is investigated.  Data from the various paradigms used in this study may 
help to improve assessment and treatment of persons with GEFS+.  
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CHAPTER II 
LITERATURE REVIEW 
A review of the literature is presented in chapter two and encompasses the 
disorder of genetic epilepsy with febrile seizures plus (GEFS+), the impact of stress in 
epileptic seizures as well as other behavioral manifestations of stress.  In addition, a 
review of omega 3 polyunsaturated fatty acids (PUFA’s) as a treatment and possible 
provider of neuroprotection is discussed.  Gaps in our understanding are also presented.  
Genetics of Epilepsy  
Researchers have been exploring genetic causes of seemingly idiopathic epilepsy.   
While they believe there are multiple (unstudied) genes that affect epilepsy, there is a 
large body of evidence revealing the impact of certain single genes (Escayg & Goldin, 
2010).  Particularly, genes that regulate or instruct voltage-gated sodium channels are a 
focus of current research.  These sodium channels are key to neuronal signaling 
(Gambardella & Marini, 2009), and if there is a disruption within the channel, alterations 
in excitation occur which can initiate seizure activity.  The sodium channel, voltage-
gated, type 1, alpha subunit (SCN1A) is the gene that instructs the alpha subunit of the 
sodium channel (Escayg & Goldin, 2010; Gambardella & Marini, 2009; Mulley et al., 
2005).  SCN1A mutation is inherited dominantly and is associated with GEFS+ and 
Dravet syndrome (Mahoney et al., 2009), and while 80% of Dravet cases have the 
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SCN1A mutation, only 10% of GEFS+ cases have the mutation leaving the other 90% of 
cases unexplained (Gambardella & Marini, 2009; Mulley et al., 2005).  This emphasizes 
the need for further study in regards to this seemingly inherited disorder.   
There are several missense (point mutations) mutations along the SCN1A gene 
associated with varying seizure phenotypes (Burgess, 2005; Zuberi et al., 2011).   
Specifically, the R1648H point mutation is linked with GEFS+ and Dravet syndrome.  In 
GEFS+, the mutation only limits the activity of the sodium channel; however, in Dravet 
syndrome, the channel has loss of function (Escayg & Goldin, 2010).  This difference in 
limited activity versus loss of function accounts for the range of severity of symptoms in 
patients with GEFS+ and Dravet.  Additionally, it is suggested that the location of the 
mutation on the gene, multiple gene involvement, and environmental factors play a part 
in the variations in phenotype (Mulley et al., 2005).  Many people view the phenotype of 
SCN1A mutation on a continuum with GEFS+ on one end and Dravet syndrome on the 
other (Gambardella & Marini, 2009).  GEFS+ is largely considered a familial epilepsy 
with the typical phenotype being febrile seizures occurring after the age of 6 or non-
febrile tonic-clonic seizures (Gambardella & Marini, 2009).  
Animal Models of Scn1a   
 In 2000, the R1648H missense mutation was discovered in a family with GEFS+ 
(Escayg et al., 2000).  Since then multiple studies have examined the effects of Scn1a 
mutations in animals.  It is important to note the difficulty in using an animal model to 
replicate a human condition with so many varying degrees of phenotypes.  Nevertheless, 
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researchers have been and continue to use animal models of GEFS+ and report various 
aspects of the genotype and phenotype.  
The Escayg laboratory has generated mouse models of the human condition of 
GEFS+ by using the R1648H (RH) mutation in the SCN1A gene.  Tang and associates 
(2009) describe how used this mouse model and tested for seizure thresholds using kainic 
acid.  These mice had decreased thresholds for seizures compared to controls.  
Interestingly, in the knock-in RH line, thresholds to kainic acid were normal; however, 
decreased thresholds to flurothyl-induced seizures were observed (Martin et al., 2010).  
They suggest the impairment of the sodium channel is in the interneurons.  This same 
group also report decreased seizure thresholds to high temp (febrile seizures), infrequent 
spontaneous seizures, and normal lifespan (Hawkins, Martin, Frankel, Kearney, & 
Escayg, 2011).  Hawkins and colleagues state, “cortical interneurons from Scn1a RH/+ 
and Scn1a RH/RH mice display slowed recovery from inactivation, increased use-
dependence, and a reduced ability to fire action potentials” (p. 655).  This means that 
there was reduced inhibition of GABAergic interneurons which can lead to abnormal 
excitability of the network.  Emphasizing even further the impact of GABAergic neurons, 
one study looked at the hippocampal synaptic transmission, specifically focusing on 
GABAergic neurons in a rat line expressing the Scn1a N1417H mutation (Ohno et al., 
2010).  In this study, they found selective alteration of GABAergic interneurons whereas 
excitatory neurons were not affected.  Thus, this study added to the body of evidence of 
SCN1A involvement with GABAergic neurons. 
 The clinical presentation of GEFS+ is complex.  A group of scientists studied a 
large four generation pedigree to examine the various phenotypes (Mahoneyet al., 2009).  
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They report a high variability that included 9 members with generalized tonic-clonic 
seizures (GTCS), 2 with febrile seizures, 5 who had experienced multiple episodes of 
status-epilepticus, 4 with absence seizures, 5 with intellectual disabilities, 3 with serious 
psychiatric disease, and 2 persons with ataxia.  Obviously there are varying ends of the 
spectrum in regards to physiological symptoms and conditions in this family with 
GEFS+.  Burgess (2005) describes the complex process of examining genotype and 
phenotype.  He states that there are probably multiple genes with multiple mutations 
involved in and linked to the GEFS+ spectrum.  It is also suggested that the environment 
plays a role in the varying phenotypes of GEFS+; however, no studies have looked at 
environmental influences on genotype and phenotype of GEFS+ (Scheffer, 2011).  
Because there are so many variations of phenotype, it is important to study these 
mutations.  It is easier to look at the impact of certain genes in animals because the 
conditions can be much more easily controlled in a laboratory environment.  This is why 
it is imperative to use animal models to elucidate certain characteristics in a disease 
model that may be difficult to isolate in humans.   
Stress and Epilepsy 
When a person encounters a stressful situation, the brain’s limbic system 
interprets the events (de Kloet et al., 2005).  If a person’s body cannot respond to stress 
adequately, it may be too difficult to return to homeostasis which can be considered 
reaching an allostatic load.  Sometimes when a person has a genetic predisposition for 
neurological issues (especially psychiatric illness), if they have reached their allostatic 
load, then this may push that person ‘over the edge’ so to speak (Karatsoreos & McEwen, 
2011) and trigger neurological issues (de Kloet et al., 2005).  It is important to note that 
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“voltage-gated ion channels’ function [are] strongly affected by corticosterone and stress” 
(de Kloet et al., 2005, p. 466) although he states that calcium channels are more affected 
than potassium and sodium channels.   
Seizure Outcomes in Response to Stress 
Although stress is considered a common trigger for seizure activity, human 
studies have had a difficult time finding relationships between a stressor and seizure 
activity.  Bosnjak and colleagues (2002) evaluated the stress of war and its impact of 
seizure activity in children.  They found that the frequency of seizures in children 
affected by war was higher than those not affected by war.  However they also report that 
qualitative data showed 10 children (total from both groups---those affected by war and 
those not affected by war) who had their first seizure during the war period were linked to 
a stressful event.  Ten children (from both groups) had their first seizure during the war 
period and were not linked to a stressful event.  What is interesting is that the children 
linked with a stressful event had higher number of absence seizures (considered less 
severe) and children whose seizures were not linked to a stressful event had a higher 
number of grand mal seizures (considered to be more severe).   
Although Swinkels and colleagues’ study (1998) found that 8 out of 30 people 
with epilepsy experiencing a stressful event (evacuation due to extreme flood threat) 
reported an increase in seizure frequency compared to controls, 33% of those with a 
change in seizure frequency had subjective reports of stress whereas 38% of those with 
no change in seizure frequency had subjective reports of stress.  Interestingly, Abel and 
Berman (1993) found anti-convulsive effects of a stressful event.  They used varying 
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durations of water immersion in an animal model of epilepsy and then examined the 
impact on seizure activity and corticosterone levels.  The longer the immersion, the 
higher the corticosterone levels, but the seizure latency to onset was increased, and these 
animals had fewer severe seizures. 
Behavioral Response to Stress in Epilepsy 
Heinrichs and Bromfield (2008) describe how an animal model can be indicative 
of behaviors in humans such as mobility, anxiety, depression, and social interaction.  
They also describe typical behaviors of rodents as grooming, stretching, and exploration.  
These researchers suggest the importance of a wide variety of assessment to include 
motor, affective, and social aspects that could provide a good overall picture of an 
animal’s somatic and psychological characteristics.  This is important because the current 
study addresses all three of these aspects.  Activity monitoring is useful in seizure-prone 
animals.  Anxiety in these types of animals can be exhibited by hyper-reactivity to a 
stressor or as less exploration (Crawley, 2000).  Depression could be exhibited by slower 
or ceased motion (Crawley, 2000).  Altered social interaction may be exhibited by 
decreased time spent with conspecific (another animal of the same species).  It is 
important to use the same gender but unfamiliar rodent when performing social 
interaction tests (Heinrichs & Bromfield, 2008).  The current study uses this technique 
with social interaction.  Heinrichs and Bromfield suggest “deficits in adaptation to stress 
and novel environments may be related to the neuronal network for functional excitability 
that impacts seizures” (p. 616). 
 
24 
 
 
 Anxiety, depression, and social stress. 
Researchers used a mouse (n = 33) model of temporal lobe epilepsy (status 
epilepticus induction by pilocarpine) and then evaluated their behavior and neurological 
status (Muller et al., 2009).  Briefly, they reported that after status epilepticus, animals 
had significantly higher anxiety behavior, increased locomotion, and decreased spatial 
learning and memory.  Surprisingly, these animals did not display evidence of depressive 
behavior.  Conversely, a different group reported increased depressive symptoms 
(increased immobility in the forced swim test) in their rat model using Long-Evans rats 
with spontaneous spike-wave discharges but very few signs of anxiety (Shaw, Chuang, 
Shieh, & Wang, 2009).   
Human studies include subjective and objective assessment of stress in persons 
with epilepsy.  One study reports that in their study population of 66 people with 
epilepsy, 44.4% had depression at some point in their life and 43.9% experienced anxiety 
(de Oliveira et al., 2011).  Of most concern, 7.6% had a suicide risk and the majority of 
those had actually attempted suicide, although none of these measures were compared to 
controls.  They did report that persons with increased frequency of seizures had a higher 
risk of suicide, emphasizing the psychological impact of seizure activity.  The Epilepsy 
Comorbidities and Health (EPIC) survey reported that in a large cohort (n = 3,488), 
people with epilepsy had a higher levels of depression, anxiety, attention deficit 
hyperactivity disorder, sleep disorders, and bipolar disorder compared to matched 
controls (Ottman et al., 2011) although another large study found no differences in 
depression between people with and without epilepsy (Novy et al., 2012).  One strength 
Ottman’s (2011) study was that their questionnaire asked if a physician had ever 
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diagnosed them with a particular psychiatric condition (multiple conditions were listed) 
rather than relying on patients’ self-report of symptoms.  Another study also found higher 
levels of depressive and anxiety symptoms in their population with epilepsy (n = 60); 
however, they relied on patient report of symptoms (de Souza & Salgado, 2006).  An 
important note is that they used highly valid tools for assessment of depression (Beck 
Depression Inventory) and anxiety (State-Trait Anxiety Inventory).   
 Alterations in the HPA axis. 
A few studies have examined the HPA axis in animal models of epilepsy.  A 
group of researchers report that El mice (a model with spontaneous seizures) had higher 
levels of corticotropin releasing factor (CRF) peptide in the paraventricular thalamic 
nucleus and as well as increased blood levels of corticosterone one hour after the stress of 
foot shock or tail suspension compared to controls (Forcelli et al., 2007).  These 
researchers did not find any alterations when the animals experienced social stress.  
Ehlers and associates (1983) report that in Sprague-Dawley rats (n = 35), CRF injected 
intracerebroventricularly “produced dose dependent patterns of EEG and behavioral 
changes different from those seen following saline injections” (p. 333).  Animals injected 
with CRF also experienced seizure activity within 1-3 hours of injection.  Additionally, 
higher CRF doses were associated with hyperactivity, increased grooming, increased 
rearing, and increased startle reaction to stimuli.   
Epilepsy and γ-Aminobutyric Acid 
 
 Epilepsy has long been associated with γ-aminobutyric acid (GABA), an 
inhibitory neurotransmitter.  Most older studies linking seizure activity and GABA used 
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pharmacological methods to either reduce GABA (to induce seizure activity in animal 
models) or increase GABA (to reduce seizure activity) (Cossette, Lachance-Touchette, & 
Rouleau, 2012).  Over the past two decades, more information explaining genetic impact 
on GABA either in regards to GABA receptors or GABAergic interneurons has been 
reported (Cossette et al., 2012; Dibbens et al., 2009).  However, until recently, the 
interaction between mutations in the SCN1A gene and GABA has remained unknown. 
Since the discovery of the important role of the SCN1A gene in epileptic 
disorders, researchers have attempted to elucidate how the gene influences seizure 
activity.  The SCN1A gene is responsible for encoding the alpha subunit in the Nav1.1 
sodium channel which is primarily expressed in the central nervous system 
(http://ghr.nlm.nih.gov/gene/SCN1A).  Because voltage-gated sodium channels are 
critical for the initiation and propagation of action potentials among neurons (Martin et 
al., 2010), it is easy to understand that disruption in these channels can alter neuronal 
signaling, thus potentially initiating seizure activity.  However, until recently, the 
mechanism of action of the disruption in the channel that led to seizures was not 
understood.  In 2010, Martin and colleagues measured electrophysiological properties of 
excitatory as well as inhibitory (GABAergic) interneurons in the cortex of genetically 
altered mice expressing the R1648H missense mutation in the Scn1a gene and found that 
the GABAergic interneurons were altered whereas the excitatory interneurons were not.  
Another group of researchers used electrophysiology to examine cells in the 
hippocampus of rats with a mutation in the Scn1a gene and noted that GABAA receptor-
mediated synaptic transmission was specifically altered over other types of synaptic 
transmission (Ohno et al., 2010).  These animals, however, had the N1417H missense 
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mutation which occurs at a different point in the Scn1a gene; therefore the dysfunction of 
the sodium channel may not be the same as with the R1648H mutation.  The combination 
of these studies emphasizes the importance of GABAergic interneurons in the etiology of 
seizure activity resulting from SCN1A mutations.   
GABA and Hyperactivity 
 Almost one-fourth of all cortical neurons use GABA.  Additionally, GABA 
subtype a (GABAA) produces inhibitory effects through direct inhibition of excitatory 
neurons, whereas GABAB subunits have a more indirect route of inhibition of excitatory 
neurons and GABAC inhibits other GABA neurons (Tamminga, Hashimoto, Volk, & 
Lewis, 2004).  GABAergic neurons are found throughout the brain, and they can affect 
different areas of the brain responsible for motor control such as the prefrontal cortex 
(PFC), striatum, substantia nigra, hippocampus and the rostral ventrolateral medulla 
(Bowman, Kumar, Hassan, McMullan, & Goodchild, 2012; Lecourtier, de Vasconcelos, 
Cosquer, & Cassel, 2010; Tamminga et al., 2004)   
The PFC is an extremely important area in terms of ADHD symptomatology 
(Brennan & Arnsten, 2008), and multiple animal studies have examined the impact of 
GABA in the PFC.  When an NMDA antagonist (which reduces GABA transmission) 
was injected into the PFC of adult male wistar rats, a significant increase in locomotor 
activity was found while simultaneous injection of muscimol (A GABA agonist) offsets 
the effects of the NMDA antagonist (Del Arco, Ronzoni, & Mora, 2011).  Additionally, 
researchers reported increased locomotor activity after injecting the PFC of Long-Evans 
rats with bicuculline (A GABAA antagonist) (Enomoto, Tse, & Floresco, 2011).  
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Homanics and colleagues (1997) examined a mouse model lacking one particular subunit 
of the GABAA receptor and found several neurological changes including seizure activity 
and hyperactivity.  These animals had severe impairment of the GABAA receptors and 
thus exhibited severe symptoms which are different compared to the disruption of 
GABAergic neurons caused by the RH mutation of SCN1A.  Lesions to cholinergic as 
well as GABAergic neurons in the septohippocampal area produced a significant increase 
in locomotor activity following an IP injection of amphetamine (Lecourtier et al., 2010) 
which indicates that the altered GABAergic response (in addition to altered cholinergic 
response) prevented attenuation of locomotor activity.  These combined studies 
emphasize the importance of GABA in relation to hyperactivity as seen in children with 
ADHD.    
Intervening with Omega 3 PUFA’s 
 General neuroprotective properties. 
 Animal studies. 
Multiple animal and human studies have examined the impact of omega 3 
PUFA’s as a treatment or neuroprotection against neurological insult or other types of 
insults.  One study used Fat-1 male mice (these mice can produce de novo n-3 PUFA’s 
from n-6 PUFA’s) to examine if they were more resistant to pentylenetetrazol (PTZ)-
induced seizures (Taha et al., 2008).  They found these mice had higher levels of brain 
DHA than wild type littermates (WT) which persisted into adulthood as well as having 
delayed seizure onset, and although p = 0.08, this may be clinically significant evidence 
of some neuroprotection.  Interestingly, only 44% of WT survived but 80% of Fat-1 
survived; however this was not statistically significant (Taha et al., 2008).  Other 
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researchers used male wistar rats (n = 20) to examine the effects of daily omega 3 
PUFA’s (85mg/kg fish oil) in prevention of neurological damage against a simulated 
epileptic seizure using pilocarpine (Ferrari et al., 2008).  They report that animals with 
induced seizures who received vehicle instead of the omega 3’s had significant cell loss 
in hippocampal subfields CA1 and CA3 compared to controls as well as compared to 
animals with induced seizures receiving omega 3’s prior to seizure induction.   
Additionally, the animals with induced seizures and omega 3 intake prior to induction 
had similar number of cells in the hippocampus (CA1 and CA3 subfields) as compared to 
controls (both controls receiving vehicle and omega 3’s but no seizure induction).  Using 
a 4:1 ratio of linoleic acid and alpha linolenic acid via IP injections daily for 21 days, 
scientists tested the anticonvulsive effects with different doses (40mg/kg, 200mg/kg, 
400mg/kg, and 1000mg/kg) (A. Taha, Filo, Ma, & McIntyre Burnham, 2009).  The 
200mg/kg dose appeared to be the most effective with a 3-fold longer latency to 
pentylenetetrazol-induced seizures compared to controls and rats receiving the 40mg/kg 
omega 3 dose and the 400mg/kg dose.  However, there was no reported difference in 
seizure severity.  In adult male wistar rats (n = 20), Cysneiros and colleagues (2010) 
performed a study using 85mg/kg omega 3 PUFA’s and seizure induction with 
pilocarpine.  The exciting results from this study are that they found preservation of 
GABAergic cells which is important for the current study because SCN1A mutations 
impact GABAergic neurons.  
An interesting study used an animal model of epilepsy but only assessed behavior.   
When comparing the differences in activity and learning in Fast rats (rats bred to be 
seizure-prone) to slow rats, Gilby and associates (2009) found few differences.  They 
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used 18%EPA and 12%DHA (~1000mg/kg of EPA/day and 700mg/kg DHA/day) in rat 
chow for approximately 3 months, and then assessed the animals on post-natal day (PND) 
90 using the open field test, Morris Water maze, and restraint.  The only significant 
difference they reported was that the Fast rats receiving omega 3 supplementation had 
decreased activity only when compared to the slow rats but not to baseline activity in the 
fast rats.  It is important to note the differences in this study and the current study vary 
widely including genotype of animal, doses/concentrations of omega 3, and route of 
administration of the omega 3 PUFA. 
There are some animal studies using omega 3 PUFA’s as neuroprotection against 
hypoxia and/or ischemia.  One study utilized adult rats undergoing cerebral artery 
occlusion that were given varying doses of DHA IV 3 hours after occlusion onset.  Low 
and medium doses of DHA led to neuroprotection (increased neurological scores and 
decreased apoptosis in cortical and sub-cortical regions) (Belayev, Khoutorova, Atkins, 
& Bazan, 2009).  Interestingly, no neuroprotection was reported with higher doses of 
DHA (70mg/kg).  Lastly, researchers used IV injections of 500nmol/kg of linoleic acid 
for 3 days prior to 6 hours of insults of either global ischemia or injection of kainic acid 
(Blondeau, Widmann, Lazdunski, & Heurteaux, 2002).  They report a significant 
decrease (almost total inhibition) of neuronal loss in CA1 and CA3 (hippocampal areas) 
compared to controls.  Another study examined 7 day old rat pups who had common 
carotid artery ligation (Berman, Mozurkewich, Liu, & Barks, 2009).  Prior to ligation, the 
pups were given varying doses of DHA, and at PND 14, the researchers tested 
sensorimotor function.  Pups supplemented with DHA had significantly better outcomes. 
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There are few animal studies that examine the impact of omega 3 PUFA’s on 
symptoms of ADHD; however they generally assess deficiencies in PUFA’s on 
locomotor activity.  Lavialle and colleagues (2008) fed female hamsters either an omega 
3 PUFA adequate or deficient diet during pregnancy through weaning and then continued 
their male offspring on the same diet through the end of testing.  At 2 months of age, the 
animals were assessed for locomotor activity, and at 3 months of age striatal lipid and 
monoamine levels were examined.  Animals receiving n-3 PUFA deficient diets had 
higher levels of locomotor activity as well as lower levels of striatal DHA.  This 
emphasizes that levels of n-3 PUFA’s obtained through diet directly impact brain levels.  
Another study examined the relationship between spontaneous levels of locomotor 
hyperactivity (as well as other symptoms of ADHD) and phospholipid fatty acid levels in 
the frontal cortex in adult rats (Vancassel et al., 2007).  Interestingly, there was a 
significant negative correlation between n-3 PUFA level in the frontal cortex and 
locomotion.  These studies did not examine the impact of n-3 PUFA supplementation; 
however they do provide insight into the relationship between n-3 PUFA and locomotor 
activity.   
 Human studies. 
There are multiple studies using human subjects that examine the effects of 
omega 3 PUFA’s as treatments for varying insults and several of these studies investigate 
uses in epilepsy.  Researchers studied people (n = 5) with epilepsy (secondary to another 
CNS disorder) and intellectual disability to examine if omega 3 PUFA supplements 
helped improve seizure activity (Schlanger, Shinitzky, & Yam, 2002).  They used a 
‘spread’ consisting of 46% DHA and 18% EPA and 1% ALA daily for 6 months.  Four of 
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the subjects who had previously had 1-8 seizures per week, had 0-1 seizures per month 
after PUFA’s.  One subject that previously had 14 seizures per week had 3 seizures per 
week after treatment (no statistical data given).  This concentration and ratio is different 
from what is normally found in the diet.  Yuen and associates (2005) performed a 
randomized, placebo-controlled trial in 56 subjects with refractory epilepsy (≥ 4 episodes 
per mo.) to examine effects on n-3 PUFA’s on seizure activity.  They used a placebo for 
12 weeks, then provided omega 3 PUFA (1g EPA and 0.7g DHA daily) for 12 weeks and 
reported that 5 out of 29 subjects taking omega 3’s had a 50% reduction in seizures 
whereas 0 out of 27 controls had 50% reduction (p < 0.05) within the first 6 weeks of 
treatment.  Unfortunately this effect did not persist beyond 6 weeks.  Other researchers 
performed a randomized trial with humans (n = 21) that used omega 3 supplementation 
(EPA:DHA ratio of 3:2) of 1.1g/day for 7 days then 1.1g/day twice per day for 13 weeks 
to examine the effects on intractable focal or generalized epilepsy (4 seizures/mo or more 
despite medication) and reported no decrease in seizure frequency of 50% or more 
(Bromfield et al., 2008).  The anti-epileptic medications and dosages that the patients 
consumed varied.  Lastly, a study that examined the use of high dose fish oil 
(9600mg/day consisting of 2800mg of omega 3 fatty acids) in 11 people with refractory 
seizures reported an increase in seizure frequency of 11%; however, the sample size is 
not adequate to provide statistical power (DeGiorgio, Miller, Meymandi, & Gornbein, 
2008).        
There are multiple, yet inconsistent, data from human studies (mostly involving 
children) regarding the impact of omega 3 PUFA’s on symptoms of ADHD.  
Hyperactivity subscale scores using a parent-rated measure of ADHD symptoms as well 
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as DSM IV criteria were significantly improved in children (n = 26) after 8 weeks of n-3 
PUFA supplementation (20-25mg/kg/day of EPA and 8.5-10.5 mg/kg/day of DHA) 
versus children with placebo (Belanger et al., 2009).  It is important to note that teacher 
ratings of ADHD symptoms did not differ between subjects and controls, although 
parents and teachers do not always agree on rating scales for symptoms of ADHD 
(Malhi, Singhi, & Sidhu, 2008).  Supplements with 400mg DHA and 40mg EPA (as well 
as 60mg of gamma linoleic acid, an n-6 PUFA, 80mg Mg, and 5mg Zinc) for 3 months in 
810 children ages 4-15 with ADHD-like symptoms significantly improved attention, 
emotional problems and hyperactivity from baseline to 12 weeks (Huss, Völp, & Stauss-
Grabo, 2010).  This study was large enough to provide adequate power of the analysis; 
however, these children were not formally diagnosed with ADHD but were evaluated 
using two tools that measured symptoms typical of ADHD (parent-rated).  Another 
randomized, double blind, placebo-controlled trial for 15 weeks with a crossover for 
another 15 weeks using a PUFA supplement (93mg EPA, 29mg DHA, 10mg gamma 
linoleic acid, and 1.8mg Vit. E) found improvements in parent ratings on the Conner’s 
Parent Rating Scale for cognitive problems/inattention, Conner’s Global Index for 
restless-impulsive behavior, and the DSM IV subscale of inattentive and hyperactive-
impulsive as well as oppositional behavior in the supplement group but not the placebo 
group (Sinn & Bryan, 2007).  There were no differences in teacher ratings on any 
subscale.  
One study examined the effects of EPA (500mg/day) exclusively and noted 
improvements in teacher-rating scale of inattention in children ages 7-12with ADHD as 
well as the combined parent/teacher ratings in children with oppositional behavior for 
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inattention and oppositionality; however, no improvements were noted for the 
hyperactivity scores (Gustafsson et al., 2010).  This study only used EPA in the 
supplement, and compared to other studies that have shown efficacy of n-3 PUFA 
supplementation on hyperactivity scores, those studies used a combination of EPA and 
DHA (as well as other substances), which suggests that DHA may impact locomotor 
activity more than EPA. 
Conversely, no effects on ADHD behaviors were noted in children ages 6-12 with 
either ADHD or suspected ADHD after two months of eating food enhanced with fish oil 
(n = 20) (equated to 3.6gram DHA/week and 700mg EPA/week) compared to those not 
eating the enhanced food (n = 20) (Hirayama, Hamazaki, & Terasawa, 2004).  It is 
difficult to compare these results with other studies in which all of the subjects had 
formal diagnoses of ADHD.  One study that did use children with a confirmed medical 
diagnosis of ADHD found no improvement in children (n = 49) who either took DHA 
345mg/day or placebo even though serum phospholipid DHA levels increased (Voigt et 
al., 2001).  One reason for this finding, however, could be that the researchers stated 
these children were all ‘effectively medicated’ prior to initiation of the study.   
There seems to be heterogeneity among the studies including age of subjects, 
length of supplementation, dose, concentration, and type of n-3 PUFA.  Additionally, the 
quantification of ADHD symptoms varies from study to study.  Fortunately, nearly all of 
the studies report few to no side effects of supplementation with dyspepsia, the aftertaste 
of fish and inability to swallow pills as the main complaints (Johnson, Ostlund, Fransson, 
Kadesj, & Gillberg, 2009; Milte, Parletta, Buckley, Coates, Young, & Howe, 2012) 
which indicates the relative ease of use in scientific research.  Although many individual 
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studies do not report significant effects of DHA or other n-3 PUFA’s on hyperactivity or 
other symptoms of ADHD, a meta-analysis conducted by Bloch and colleagues (2011) 
concluded that there was a “small but significant” effect of n-3 PUFA’s on hyperactivity, 
although EPA appeared to be the most significant.  These researchers felt that maybe that 
the individual studies may have been under-powered or have other methodological issues.    
 Administration of omega 3 PUFA’s. 
Whenever an agent, even a complimentary medicine, is used in an experimental 
design, it is important to consider dosage, route, and timing of administration.  In 2005, 
Yuen and colleagues found results in their human study with 1.7g n-3 PUFA (1g EPA 
and 0.7g DHA daily), but seizure improvement was short-lived.  They speculated that the 
dose was too low.  Another set of researchers found dose-dependent anticonvulsant 
effects using a combination of linoleic acid and alpha-linolenic acid (4:1 ratio) (Taha et 
al., 2009).  The dose of 200mg/kg seemed to be the most efficacious as well as 
minimized abdominal bloating and weight loss issues in rodents.  One animal study found 
that 14mg/kg of DHA worked the best in preventing apoptosis or neurological damage 
from middle cerebral artery occlusion (Belayev et al., 2009).  Another study utilized 
400mg/kg of DHA to examine effects on PTZ-induced seizures (Taha et al., 2010).  Yet 
another study used DHA 12mg/kg to examine impact on kindled seizures (Musto, 
Gjorstrup, & Bazan, 2011).  Human studies are similarly inconsistent with ranges of 
DHA between 500mg/day to 1200mg/day or more (Campoy et al., 2011; Helland et al., 
2008).  Interestingly, a group studied plasma fatty acid levels in patients on 
carbamazepine (an anti-epileptic agent) and found the patients had lower levels of omega 
3’s even after they were given omega 3 supplements than patients on oxcarbazepine 
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(Yuen et al., 2008).  Therefore it is important to consider whether or not patients are on 
anti-epileptic medications when giving omega 3 fatty acids.  Some patients are on 
multiple medications which could further impact omega 3 levels.   
The route of omega 3 PUFA administration varies widely among animal studies 
and includes oral (via the chow) (Willis, Samala, Rosenberger, & Borges, 2009), 
intraperitoneal injections (Taha et al., 2009), subcutaneous injections (Taha et al., 2010), 
as well as intravenous injections (Musto et al., 2011).  Human studies have consistently 
used oral intake of omega 3 PUFA’s in studies.  Sinha and colleagues (2009) report 
increased levels of omega 3 fatty acids in the neonate after omega 3 fatty acid 
supplementation during pregnancy suggesting the ability of n-3 PUFA’s to cross the 
placenta.  Dyall (2011) states there are inconsistencies regarding dosage, route and 
combinations of omega 3 PUFA’s in various research studies.  Additionally, researchers 
must be careful with storage (degradation of the n-3’s) and preparation (high heat 
degrades the n-3’s), and specify route of administration as well as dosage (must be 
careful to specify the ratio and exactly what is in the preparation).   
 Mechanism of action. 
 Phospholipid bilayer. 
There is emerging evidence for the mechanism of action of omega 3 PUFA’s as 
neuroprotection or treatment for neurological injuries, but there is still more research 
needed in this area.  This first mechanism of action involves the lipid membrane.  The 
lipid bilayer of cell membranes has a critical function in cell signaling.  This layer 
prevents ions and other molecules from entering or leaving a cell until the correct 
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moment (Lundbaek, Collingwood, Inglfsson, Kapoor, & Andersen, 2010).  Dysfunction 
of this membrane causes premature or delayed compartmental shift of ions leading to cell 
dysfunction.  DHA is reported to modulate cell membrane properties (Schuchardt et al., 
2009; Taha et al., 2010).  Specifically, DHA is mainly localized to the lipid bilayer 
compartment of cells (Yavin, 2006).  DHA helps various membrane proteins, such as 
receptors, channels and enzymes, to function properly (Mourek, Langmeier, & Pokorny, 
2009).  This appears to be the result of improved elasticity of the membrane (Bruno, 
Koeppe, & Andersen, 2007; Sogaard et al., 2006).  When proteins located within the 
membrane undergo conformational changes, they exert energy on the lipid bilayer which 
can result in deformation of the bilayer to a certain degree.  If the bilayer is ‘stiff’ (less 
elastic), then the deformation is greater thus impairing protein function (Bruno et al., 
2007) (see Figure 3).  This emphasizes the importance of the need to examine the impact 
of omega 3’s in the central nervous system (CNS).   
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Anti-inflammation 
Taha and colleagues (2010) suggest that omega 3 PUFA’s also have anti-
inflammatory properties.  In addition, Schuchardt and associates (2009) state that PUFA 
deficiency could lead to abnormal immune response which could also be a potential 
mechanism for action.  Spirer, Koren, Finkelstein, and Jurgenson (1994) speculate 
that,“n-3 polyunsaturated fatty acids reduce the synthesis of IL-1, the main molecule 
responsible for fever…” p.43.  Additionally, one study found that prenatal DHA and EPA 
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decreased inflammatory markers in the neonatal rat pup (Zhang, Hu, Yang, Gao, & Chen, 
2010).  One human study reported that a 12 week placebo-controlled RCT using omega 3 
PUFA supplements in healthy medical residents had a 14% lippopolysaccaride-induced 
interleukin 6 (an inflammatory marker) production (Kiecolt-Glaser, Belury, Andridge, 
Malarkey, & Glaser, 2011). 
Neuroprotectin D 
There is also emerging evidence regarding the impact of Neuroprotectin D 
(NPD1).  Neuroprotectin D (Belayev et al., 2009) is believed to be a signaling molecule 
with anti-inflammatory and anti-apoptotic properties (Bazan, 2006; Bazan et al., 2011; 
Lukiw & Bazan, 2006).  A group of researchers utilized retinal pigment epithelial cells to 
demonstrate the synthesis of NPD1 after DHA was added to these cells (Mukherjee, 
Marcheselli, Serhan, & Bazan, 2004).  They suggest that DHA is a precursor to NPD1.  
Gaps in our Understanding 
The purpose of this study was to build upon animal models of genetic epilepsy 
with febrile seizures plus (GEFS+).  The gaps in our understanding of the human 
condition of GEFS+ include behavioral phenotypes as well as the seizure response to 
stress.  In addition, very little information regarding the use of neuroprotectants against 
co-morbid traits such as hyperactivity is reported.  This study will help to fill these gaps 
in the literature.  Results from this animal model will permit us to extrapolate data to 
humans with GEFS+, allowing us to further explore previously unknown phenomenon.  
Additionally, specific treatment and preventative techniques may be employed in the 
human population, thus decreasing morbidity and improving quality of life.  
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CHAPTER III 
METHODOLOGY 
            Chapter three consists of a description of the design for the study.  The study 
sample as well as details of each experimental paradigm is included.  Lastly, the plan for 
analysis of the data is presented.     
Research Plan 
Research Design and Methods 
 A descriptive, experimental design used restraint stress as well as other behavioral 
tests to investigate specific seizure phenotypes as well as behavioral responses in a mouse 
model of genetic epilepsy with febrile seizures plus (GEFS+).  All mice were genotyped 
and housed using standardized Emory animal care and use protocols 
(http://www.dar.emory.edu/HOME/index.php).  Mice were selected for each experiment 
by another researcher in the Escayg lab to make sure the appropriate numbers of subjects 
and controls were tested, but I was blind to the genotypes of the mice.  One group of mice 
underwent seizure induction using picrotoxin.  Another set of mice underwent behavioral 
testing.  A third set of mice received SQ injections of docosahexaenoic acid and 
underwent locomotor testing at post-natal day (PND) 35.  All experiments were 
completed under the approval of the Institutional Animal Care and Use Committee at 
Georgia State University and Emory University (see Appendices E and F).  
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Description of the Genetically Engineered Mice in this Study 
Escayg and colleagues (2000) discovered the R1648H missense mutation in a 
family with GEFS+.  In 2010, Dr. Escayg’s lab was able to genetically engineer the 
C57BL/6J mouse by knocking in the R1648H (RH) missense mutation on the Scn1a gene 
(see Figure 4) (Martin et al., 2010).  The animals in this study are heterozygous for the 
mutation and only have partial dysfunction of the channel.  While these particular mice 
have had testing regarding seizure phenotype (Hawkins et al., 2011; Martin et al., 2010), 
they have never had extensive  behavioral testing done, nor has the impact of stress on 
seizure phenotype been assessed in the RH mice.  C57BL/6J mice (see Figure 5) were 
selected for this study because they are commonly used in laboratory testing (especially 
behavioral testing) and are considered good for examining genetic modification (Muller 
et al., 2009).  
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Figure 4 The location of dysfunction within the sodium channel from the R1648H 
missense mutation  
Adapted  From 
http://www.nature.com/nature/journal/v409/n6823/images/409988aa.2.jpg  
 
Figure 5  Photograph of the C57BL/6J mouse 
 
Source: http://www.brc.riken.go.jp/lab/animal/images/mn050531_0101.png    
The wild-type mice were originally obtained from Jackson Laboratories (Bar 
Harbor, Maine).  Male mice were used for specific aims I and II to control for any 
hormonal variations that might impact the data.  For specific aim III, both male and 
female mice were used. 
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When the pups were 12 days old, they underwent genotyping (Appendix D) and 
were tagged for identification purposes to confirm their genetic mutation and logged in a 
separate notebook for future data purposes.  All of the mice in each experiment were born 
from the 12th generation of mutants which ensures purity of the genetic mutation, and 
they weighed an average of 25grams.  For specific aim I and II, all testing was conducted 
at PND 90.  This age is considered adulthood for mice, a time after brain development 
has occurred (Crawley, 2000).  For specific aim III, testing was completed at PND 35.   
Animal Setting 
All animals were maintained in a specialized facility for small laboratory animals. 
Emory University’s Division of Animal Resources and Institutional Animal Care and Use 
Committee (IACUC), as well as Georgia State University’s IACUC, approved all 
experiments and procedures in this study.  Laboratory animals had corn cob bedding, 
water and standard chow ad libitum.  The environment and had controlled temperature 
and humidity.  The animal’s normal circadian rhythm runs on a twelve-hour light/dark 
cycles (0700-1900 is lights on; 1900-0700 is lights off) and this cycle was maintained 
(http://pubs.niaaa.nih.gov/publications/arh25-2/85-93.htm).  Mice will sleep during the 
day and stay awake during the night (http://pubs.niaaa.nih.gov/publications/arh25-2/85-
93.htm).  The mouse’s normal sleep time is appropriate for behavioral testing because 
this is a period of time when the animal is calm.  Also, because the testing is done in a lit 
room, it is appropriate to perform tests during the animal’s normal ‘lights on’ time so 
their circadian rhythm is not altered (http://pubs.niaaa.nih.gov/publications/arh25-2/85-
93.htm).  Emory laboratory personnel, as per routine guidelines for laboratory 
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maintenance and safety (http://www.dar.emory.edu/HOME/index.php), cared for animals 
in between testing.   
Specific Aim I: To establish the picrotoxin-induced seizure phenotype of 
unrestrained as well as restrained (stressed) R1648H (RH) mice compared to wild-
type (WT) mice (both restrained and unrestrained).   
Rationale. There are data that demonstrates the reduced threshold for febrile-induced 
seizures as well as to flurothyl-induced seizures (Martin et al., 2010); however, the full 
extent as to the impact of stress in induced seizures is not understood.  Multiple human 
studies report that stress is the most common trigger of seizure activity (Bosnjak et al., 
2002; Ottman et al., 2011); however, it is difficult to ascertain if the stress was the actual 
trigger, or if the stress lead to sleep alteration which is also shown to be a trigger.   None 
the less, a retrospective study attempted to control for effects of confounders and report 
that stress was an independent trigger for seizures in people experiencing a traumatic 
evacuation from their home (Swinkels et al., 1998).  In regards to animal studies, there 
are conflicting results reporting some anti-convulsive effects as well as pro-convulsive 
effect of stress.  For example, Abel and Berman (1993) report that seizure latency 
increased with increasing duration of water immersion.  However, pro-convulsive effects 
of stress were reported in an animal model of epilepsy in response to tail suspension 
(Forcelli et al., 2007).  This aim addressed the conflicting data and gaps in the literature 
regarding the seizure phenotype of the RH mouse in response to stress.   Data from the 
Escayg lab revealed that C57BL/6J mice with the RH mutation have decreased thresholds 
to flurothyl-induced seizures (Martin et al., 2010); therefore, we used the RH mice to 
examine picrotoxin-induced seizure phenotypes in response to stress.  The use of 
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picrotoxin allows the researcher to examine a broad spectrum of the seizure phenotypes 
including types and durations of different seizure activities (see measures below).   
Experimental Design 
 Cohorts.   
We established 4 cohorts of mice that were distinguished by their genotype and 
stressed condition: RH (stressed and unstressed) versus wild-type (WT) (stressed and 
unstressed).  At PND 90, these two cohorts were randomly and evenly divided (by 
another researcher; therefore, this researcher was blind to the genotypes) into ‘stressed’ 
and ‘unstressed’ animals (n = 12 for each of the four separate groups).  One week prior to 
all testing, the animals were single-housed and maintained in standard housing with water 
and rodent chow available ad libitum.  During experimentation, the room was quiet and 
controlled for environmental conditions that may induce stress.  Every effort was made to 
minimize animal suffering.  
Seizure-induction protocol. 
There were a total of 8 groups of animals consisting of 6 animals each (24 RH 
mutants and 24 WT littermates---12 stressed and 12 unstressed for each genotype) so that 
during testing only 6 animals underwent experimentation at a time.  All tests were 
performed in the morning between the hours of 0900 and 1200 to maintain consistency 
and control for any impacts from hormonal circadian changes.  This is also during the 
sleep cycle of the mouse; therefore, they should be calm and quiet during this period 
which would reduce any concern for confounders of activity level.  Two hours prior to 
testing, the animals were moved to the experimental room to allow them to acclimate to 
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the new room and to settle down from the movement of their cages.  During 
experimentation, a researcher randomly but evenly assigns a few ‘stressed’ animals and 
‘non-stressed’ animals to be in each group during testing.  The stressed animals 
experience restraint stress by being placed in a small tube in which they were not able to 
move.  The restraint lasted 20 minutes.  The animals were then, one at a time, removed 
from the tube, weighed, and then injected with picrotoxin at a concentration of 5mg/kg 
via injection into the peritoneum.  This particular dose was found by researchers in the 
Escayg lab to be an effective dose for initiating seizures as well as not being toxic to the 
RH mice.  The researcher used aseptic technique in the injection process.  Each dose was 
calculated based on the weight of the mouse and was adjusted accordingly (all mice were 
injected with the same concentration).  The mice were then placed in a clear plexiglass 
box for observation.  Care was taken to ensure accurate identification of the animal when 
it was placed into a novel environment.  This makes certain that the genotype of the 
animal can be traced once data collection is complete.  To ensure accurate recording of 
the data, each animal was videotaped for one hour using a Cannon ZR850x camera 
placed on a tripod.  Animals that were not placed in restraint stress underwent the same 
procedure as above with the exception of the stressor.  Once the hour of observation was 
completed, the animals were removed from the plexiglass box and returned to their cage.  
Care was taken to ensure consistency with each step of the procedure to maintain control 
as well as to minimize suffering of the animal.   
Measures.   
The animals were videotaped for one hour to examine the picrotoxin-induced 
seizure phenotype.  During experimentation, the researcher observed the mice and took 
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notes for future references to when times of possible seizure activity occurred.  After all 
experimentation was completed, the researcher viewed the videotapes and calculated the 
times for latency to each type of seizure activity (as described below), length of seizure 
activity, numbers of different types of seizure activity as well as the specific type of 
seizure activity.  Internal consistency was established by having the main researcher’s 
observations confirmed by blinded observations from another researcher in the Escayg 
lab for the first several mice.  Additionally, the main researcher observed several of the 
videos on more than one occasion to make sure consistency in recording the data was 
maintained.  All data was recorded and calculated by the main researcher.  All data was 
recorded on a flow chart (see Appendices A and B) and in a laboratory book as well as on 
a secured Excel file.  All calculations were double-checked for accuracy.  
Myoclonic jerk.  
Each mouse was observed for the first myoclonic jerk.  The myoclonic jerk is the 
first sign of impending seizure activity (Papandrea, Kukol, Anderson, Herron, & Ferland, 
2009).  The neurons are starting to have increased excitation, and the myoclonic jerk 
comes prior to any type of partial or generalized seizure.  The frequency of myoclonic 
jerks was also calculated by dividing the total number of myoclonic jerks by the total 
time recorded. 
Partial or generalized seizure. 
Another measure of seizure phenotype is latency to partial or generalized seizures.   
Partial seizures are seizures involving only a specific area of the brain and generalized 
seizures are global and cause a loss of posture (http://www.epilepsyfoundation.org/).   
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Partial seizures are also classified as a focal seizure in which only a small part of the 
body exhibits clonus (usually the jaw, head movement or one forelimb).  Bilateral 
forelimb clonus is also considered a partial seizure with more significant brain 
involvement consisting of both forelimbs rapidly moving.  Generalized tonic-clonic 
seizures (GTCS) are a more severe type of seizure.  This type of seizure activity includes 
massive intermittent muscle contraction causing the animal to literally bounce around the 
box.  Each of these types of seizures was recorded for latency to onset, frequency and 
duration.  The frequency was calculated by dividing the total number of seizures (partial 
and generalized calculated separately) by the total time recorded.  
Hind limb extension. 
Occasionally after a severe or prolonged seizure, the mouse will have hind limb 
extension.  The back legs will extend and stiffen as straight as possible in relation to the 
body.  Mice can recover from hind limb extension or sometimes they expire after this.   
Sometimes the animal that recovers will continue to have generalized seizures or GTCS.   
These were recorded as either present or absent.  
Status epilepticus. 
Other measures include whether or not the animal experienced status epilepticus 
with consists of a seizure lasting greater than 15 minutes.  Field notes included any sort 
of aberrant activity during the recording.   
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Seizure severity. 
Seizure severity can be measured by recording the total time observed in seizure 
activity.  Because some animals died during the seizure paradigm, we also calculated the 
total percentage of observed time spent in seizure activity including both partial and 
generalized seizures.  A modified Racine scale was also used to determine the highest 
level of seizure activity experienced by each animal (Racine, 1971).  See Appendix A for 
the modified Racine Scale used for this study.  
Fecal Boli. 
The number of fecal boli was measured because increased number of boli may 
signify anxiety-like behavior (Crawley, 2000).  After the test, the number of fecal boli 
was counted and recorded for further comparison.   
Sample Sizes and Statistical Analysis 
This aim generated 4 groups of mice (WT stressed and unstressed and RH 
stressed and unstressed) to examine the picrotoxin-induced seizure phenotype.  The 
subdivision was done so that an even number from all four subsets occurred (this 
researcher was blinded to the genotype).  Based on values derived from prior studies in 
the Escayg Lab, we determined that 48 animals (12 in each subset) would provide an 
alpha of 0.05 and statistical power of 0.80.  We sought to minimize the number of 
animals needed for the project.  If insufficient power was detected at the end of 
experimentation, additional animals were studied.  Due to multiple groups of animals, we 
used 2-way ANOVA with Tukey’s post-hoc analysis.  Additionally, all data were 
assessed using the Grubb’s test for outliers as well as descriptive statistics to obtain 
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mean, standard deviation and standard error of the mean.  Each measure was analyzed 
separately.  Additionally, a p < 0.05 was considered statistically significant.  
Specific Aim II: To establish the behavioral response to stress using multiple 
behavior experiments in the RH mice compared to WT mice.  
 Rationale. There are studies that have examined the behavioral response to stressful 
events in animals with epilepsy; however, the data are limited.  One study reported 
depressive behaviors in rats with spontaneous spike-wave discharges, but did not really 
find any abnormality with anxiety (Shaw et al., 2009).  Conversely, a study reported 
increased anxiety but lower depressive symptoms in mice with pilocarpine-induced status 
epilepticus (Muller et al., 2009).  These conflicting data emphasize the need for further 
study.  And although Muller and associates (2009) used the C57BL/6J mouse for their 
model, these mice did not have a sodium channel mutation; therefore it is somewhat 
difficult to extrapolate results.  Preliminary data from the Escayg lab (unpublished data) 
found altered behavioral responses to predator odor and novelty environment in the 
C3HeB/Fe mouse which has Scn8a (another sodium channel) mutation; therefore we can 
speculate that another model of sodium channel mutation may have altered behavioral 
responses.  This aim will fill the gaps in the knowledge of behavioral response to various 
stressful events in the RH mouse.  
 Experimental Design   
 Specific aim II involves a longitudinal design because each animal was subjected 
to various behavioral paradigms over a period of time.  All animals within each genotype 
were randomly assigned to an experimental group because only 6 animals can be tested in 
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one day.  However each animal underwent the same routine of behavioral testing as 
described below.  
Table  1   Groups 1-4:  A separate group of animals (n = 6 each) undergoing each specific 
behavioral paradigm 
 
 Cohorts.  
 Two cohorts were created for these experimental paradigms.  One cohort was 
comprised of RH mice (n = 12) and the other cohort was wild-type (n = 12).  At PND 90, 
these mice underwent multiple behavioral paradigms, with each paradigm being 
separated by 2 weeks to reduce chance of stress resulting from one paradigm impacting 
the next paradigm (see Table 1).  The paradigms include the open field test, forced swim 
test, novelty environment, and social stress test.  Performing multiple behavioral 
paradigms reduces the number of animals needed for the experiment.  Additionally, one 
group of animals (n = 20, 10 RH and 10 WT) underwent testing using the predator odor 
Behavioral 
Paradigm 
Week 
1 
Week 2 Week 3 Week 4 Week 5 Week 6 Week 
7 
Week 8 Week 
9 
Week 
10 
Open 
Field 
Group 
1 
Group 
2 
Group 
3 
Group 
4 
      
Forced 
Swim 
  Group 
1 
Group 
2 
Group 
3 
Group 
4 
    
Novelty 
Cage 
    Group 
1 
Group 
2 
Group 
3 
Group 
4 
  
Social 
Interaction 
      Group 
1 
Group 
2 
Group 
3 
Group 
4 
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paradigm.  It was decided to use this paradigm on a separate group of animals because of 
the extensive nature of the test (see measures below).  One week prior to the beginning of 
testing, the animals were single-housed and maintained in standard housing with water 
and rodent chow available ad libitum.  During the entire behavioral testing process, the 
animals remained single-housed and then were sacrificed at the end.  During 
experimentation, the room was quiet and controlled for environmental conditions that 
may induce stress.  Every effort was made to minimize suffering of the animals. 
 Protocol and measures. 
All measures were observed by the researcher during experimentation; however, 
each test was video-taped so the researcher could review each test to ensure accuracy of 
recording of data.  Internal consistency for recording data was maintained in the same 
manner as described in specific aim I with the only exception being that behavioral 
phenotypes were observed in this second aim as opposed to seizure phenotype in specific 
aim I.  Many of the data was coded by computerized software [Anymaze software from 
Stoelting Co. (Illinois)]. 
Open field. 
 There was a total of 4 groups of animals consisting of 6 animals each (total of n = 
12 for RH mutants and n = 12 for WT littermates, all randomly selected).  All behavior 
paradigms were performed in the afternoon starting between the hours of 1200 and 1400.  
At each time of testing, only 6 animals underwent experimentation in order to maintain 
the window of time of 4 hours to maintain consistency and control for any hormonal 
circadian changes.  This is also the sleep cycle of the mouse; therefore, they should be 
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calm and quiet during this period which would reduce any concern for confounders of 
activity level.  Two hours prior to testing, the animals were moved to the experimental 
room to allow the animals to acclimate to the new room and to settle down from the 
movement of their cages.  Each animal was placed into the center of a 24 in. x 24 in. 
opaque plexiglass box with smooth cardboard bottom.  Using a video camera (Cannon 
ZR850x), the mice were tape-recorded for 15 minutes to examine their locomotor and 
behavioral response to a novel open field environment.  Once the 15 minutes had 
surpassed, the animal was removed from the box, fecal boli were counted, and the area 
was cleaned prior to introducing the next animal.   
We examined four measures in the open field test.  The first was the total duration 
of time spent in the center.  Generally, mice like to explore a new environment, and time 
spent in the center is indicative of normal exploratory behavior (Heinrichs & Bromfield, 
2008).  The second measure was total duration of time spent in the perimeter of the field.  
More time spent in this area is suggestive of anxiety-like behavior.  The third measure 
was the total distance traveled.  This allowed examination of locomotor activity.  We 
used Anymaze software from Stoelting Co. (Illinois).  Using the software allowed for 
rigor, consistency, and accuracy of measurements.  The fourth measure was the number 
of fecal boli.  Under stressful conditions mice tend to have increased fecal boli.   
Forced swim test. 
The second paradigm in the behavioral testing was the forced-swim test (see 
Figure 6).  As stated earlier, this test was conducted two weeks after the open field test.  
Timing and pre-experimental protocol was the same as stated above.  A large glass 
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beaker was filled with approximately 3500 mL of water that was room temperature (25°C 
± 1°C).  The animal was placed in the center of the container and videotaped (Cannon 
ZR850x) for 10 minutes.  Once the experiment was completed, the animal was removed, 
dried and returned to the housing unit.  The temperature of the water was analyzed prior 
to each animal and was adjusted as needed.  Additionally, the water was changed after 3 
animals.   
Figure 6  Mouse undergoing Forced Swim Test 
 
There were only two measures that were assessed during the forced swim test: 
total time spent immobile and total time spent struggling.  Immobility during this test is 
considered a sign of depression and has been used by many researchers in tests for 
depression as well as anti-depressant medications (Castagné, Moser, Roux, & Porsolt, 
2001; Crawley, 2000).  Active struggling (as defined by active movement of forelimbs 
and hind limbs and vertical direction of the animal’s body) was recorded as well. We 
used Anymaze software from Stoelting Co. (Illinois).  The researcher calculated the total 
time spent in active struggling with the help of Anymaze software.  Using the software 
allowed for rigor, consistency, and accuracy of measurements. 
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Novelty cage.  
 The third behavior paradigm was the novelty cage.  Even though the open field 
test was a new environment, the novelty cage experiment allowed us to examine other 
behaviors that we could not see in the open field test.  This test was performed two weeks 
after the forced swim test.  Timing and pre-experimental protocol was the same as stated 
above.  Each animal was placed in a new 12.2 in. x 6.5 in. cage with new corn cob 
bedding and videotaped (Cannon ZR850x) for 15 minutes.  Once the experiment was 
completed, the animal was removed, and fecal boli were counted.  Each animal was 
placed in a completely separate cage for the testing.  
 There were several measures that were examined during the novelty cage 
experiment (Appendix C).  The first measure examined the frequency of ‘stretch-attend’ 
movement.   This behavior is characterized by the mouse keeping the hind limbs in place 
but stretching forward with upper body to examine an area.  Stretch-attend behavior is a 
sign of anxiety because the mouse does not want to leave its original position to explore 
(Bailey & Crawley, 2009).  The second measure was the frequency of grooming behavior 
and the third measure was the duration of grooming behavior.  A normal behavior of 
rodents is to self groom, and any anxiety or altered behavioral state could change the 
frequency and duration of grooming (Heinrichs & Bromfield, 2008).  The fourth measure 
was frequency of rearing behavior with wall touch which indicates exploratory behavior 
(normal in a mouse) (Bailey & Crawley, 2009).  The fifth measure was the total duration 
of burrowing activity.  Burrowing is a natural behavior for mice and stressful situations 
may alter this activity (Thomas et al., 2009).  The sixth measure was the total duration of 
staring. Staring is considered a response to a threat and higher anxiety (Heinrichs & 
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Bromfield, 2008).  The seventh and last measure was the number of fecal boli.  Increased 
number of fecal boli can be indicative of anxiety-like behavior (Crawley, 2000). 
Social Interaction Test. 
 Another behavioral paradigm that was used is the social interaction test (see 
Figure 7).  This test was performed two weeks after the novelty cage environment.  
Timing and pre-experimental protocol was the same as stated above.  A large, clear 
plexiglass box was used for this experiment (see Figure 8).  Below is a diagram with 
measurements of the box.  First, the test mouse was placed in the center of the box for 10 
minutes.  Then a ‘stranger’ conspecific (C3HB/Fe) wild type mouse was placed into one 
of the corner boxes for 10 minutes.  Each corner box has holes to allow the test mouse 
detect the odor from the conspecific.  Then another ‘stranger’ conspecific (C3HB/Fe) 
wild type mouse was placed in the other corner box for 10 minutes.  Each stranger mouse 
was used twice in the entire set of 6 animals and was placed in the opposite corner from 
the first time it was used.  The total time for this experiment was 30 minutes and was 
videotaped with the Cannon ZR850x camera the entire time.  Once the experiment was 
completed, the animals were removed and fecal boli were counted.  The boxes were 
cleaned between each animal. 
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Figure 7  A photograph of the Social Interaction Paradigm with all 3 mice 
 
Figure 8  Diagram and measurements of the Social Interaction box 
                       61 cm         
                8.25cm X 8.25cm      
 41 cm                             27 cm                        27 cm            22 cm high 
  
 
There were several measures that were examined in the social interaction test.  
First, the total duration of time spent in the center of the box was calculated.  We also 
examined locomotor activity for the animal when no stranger was present.  This allows us 
to compare data found in the open field paradigm regarding locomotor activity.  To detect 
if the animal preferred social interaction with a stranger mouse versus an empty area 
Stranger 2 mouse 
Stranger 1 mouse 
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(sociability), we recorded the time spent and number of entries into the large segmented 
zone that held the stranger mouse (1/3 of the total area).  The first stranger is the actual 
‘stranger’ for the first 10 minutes of stranger introduction.  When the second stranger was 
introduced, the first stranger became the ‘familiar’ and the second stranger became the 
‘new stranger.’  To determine if the mouse preferred a ‘new’ stranger mouse over the 
‘old’ stranger mouse (social novelty), we examined the interaction of both the RH 
mutants and their WT littermates with the novel stranger mouse compared to the older 
(thus more familiar) stranger mouse.  Normally, mice would investigate new mice placed 
into their environment.  Increased time spent away from the stranger is considered a sign 
of anxiety (Heinrichs & Bromfield, 2008).  Another measure was the number of 
approaches within the perimeter of the stranger box when the stranger mice were present.  
This gave another quantitative measure of exploration of the conspecific.  We used 
Anymaze software from Stoelting Co. (Illinois) to record data.  Using the software 
allowed for rigor, consistency, and accuracy of measurements.  Lastly, the number of 
fecal boli was counted.    
Predator odor test. 
 The last behavioral paradigm was the predator odor test.  As stated above, the 
predator odor test was completed on a separate set of animals (n = 20) due to the 
prolonged nature of the experiment.  All of the predator odor experiments were 
conducted in the morning, starting between the hours of 0800 and 1000.  Pre-
experimental protocol was the same as stated above.  On the first day of the protocol, the 
mouse was placed into a clear plexiglass box (10.75 in. deep, 10.75 in. wide, 11.25 in. 
high) for 15 minutes to become familiarized with the environment (this was done to 
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control for novelty).  On the third day (there was a day separating each phase of this 
experiment), the mouse was placed in a different but identical box but this time with 
predator odor (trimethylthiazoline 1%) for 15 minutes.  On the fifth day of the protocol, 
the animal was placed in the same plexiglass box with no odor for 15 minutes.  Each 
phase of the experiment was videotaped.  Once each phase of the experiment was 
completed, the mouse was removed and the box was thoroughly cleaned and air-dried.  
 There were two measures assessed during the predator odor test.  The first 
measure was the total duration of freezing.  Freezing is a defensive behavior and is 
expected to some degree in response to a predator (Janitzky et al., 2009).  The other 
measure was total duration of grooming which is a non-defensive behavior.  We used 
Anymaze software from Stoelting Co. (Illinois).  Using the software allowed for rigor, 
consistency, and accuracy of measurements.  
For all behavioral measures not indicated as being analyzed by the Anymaze 
software, the researcher analyzed and recorded the data for each mouse  
Sample Size and Statistical Analysis 
This aim generated 2 cohorts of mice to examine the behavioral response to 
multiple paradigms (which were in themselves stressors) in RH or WT mice.  The 
researcher was blind to genotypes during all testing.  Based on previous research and the 
experience of the Escayg lab, it was determined that 24 animals (n = 12 RH mutants and 
n = 12 WT mice, 4 groups of 6 in each test set) would be sufficient to provide power to 
the analysis as well as statistical significance.  Performing multiple tests on the same set 
of animals also minimizes the number of animals needed for the project to ensure 
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conservation as best as possible.  Because the predator odor test must be conducted on a 
separate set of animals, we used a conservative number (n = 20, 10 per group).  For the 
open field paradigm, novelty cage paradigm, forced swim test, and the total measures in 
the empty box for social interaction paradigm, an independent t-test was used to analyze 
data from the two groups.  A repeated measures two-way ANOVA was used to analyze 
social interaction (sociability and social novelty) and predator odor data.  For all tests 
using ANOVA, post-hoc analysis was also conducted using Tukey’s test.  Additionally, 
all data were assessed using the Grubb’s test for outliers as well as descriptive statistics to 
obtain mean, standard deviation and standard error of the mean.  Each measure was 
analyzed separately. Lastly, a p < 0.05 was considered statistically significant.  All of the 
data were analyzed using Sigmaplot 11.0 software.   
Specific Aim III: Determine the neuroprotective effects of subcutaneous injections 
of docosahexaenoic acid (an omega 3 PUFA) on hyperactive behavior in RH mice. 
Rationale.   The available data from human studies report varying degrees of efficacy of 
omega 3 PUFA’s as treatment for symptoms of ADHD.  Additionally, the subjects and 
methods appear to have variability.  There are few animal studies assessing the efficacy 
of n-3 PUFA’s on hyperactive behavior, and none of these include studying the effects of 
n-3 PUFA’s on neurological sequelae in GEFS+.  Therefore, we chose to assess the 
potential neuroprotective effects of omega 3 PUFA’s in this animal model of GEFS+.  
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Experimental Design 
 Cohorts.  
Six groups were created for this experimental paradigm.  Two groups were 
comprised of mice (both RH mutants n = 10, and WT mice, n = 10) receiving 
subcutaneous injections of DHA 100mg/kg for 2 weeks starting at PND 21 (time of 
weaning).  Two groups consisted of control mice (both RH mutants n = 10, and WT 
mice, n = 10) receiving subcutaneous injections of vehicle (oleic acid 100mg/kg) for 2 
weeks starting at PND 21 (time of weaning).  The final two groups consisted of control 
mice (both RH mutants n = 10, and WT mice, n = 10) that did not receive any injection 
and were considered as ‘unhandled controls.’  Both the DHA and oleic acid come from 
Sigma-Aldrich Products, St. Louis, MO.  Once the pups were weaned, they were 
randomly divided into cohorts (evenly distributed between RH mutants and WT group).  
The pups from each cohort (both male and female) underwent behavioral testing using 
the open field paradigm at PND 35.  The pups remained in group-housed standard cages 
with water and rodent chow available ad libitum.  During experimentation, the room was 
quiet and controlled for environmental conditions that may induce stress.  Every effort 
was made to minimize suffering of the animals. 
Protocol. 
Starting at weaning (PND 21), each pup was injected SQ with either DHA 
100mg/kg or vehicle (Oleic acid 100mg/kg) or remain unhandled for 14 days.  Aseptic 
technique was used for each injection, and injection sites were either in the scruff of neck 
or on the back.  On day 15, each pup underwent the open field test.  The open-field 
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protocol was the same as described earlier except that animals were group-housed after 
weaning instead of single housed.    
 Measures. 
 The same measures as described earlier for the open field paradigm were 
documented.  These experiments were video-taped using the Cannon ZR850x camera to 
ensure accurate recording of activity.  The same researcher coded all the data.   
Sample Size and Statistical Analysis 
 Based on experience of the Escayg lab, it was determined that 60 animals (20 in 
each cohort—10 RH mutants and 10 WT mice) should be sufficient to provide enough 
power to the analysis.  After analysis, if statistical power was not reached, more animals 
would be tested in future experiments.  A two-way ANOVA statistical test was used to 
examine differences between the groups.  Tukey’s post-hoc analysis was also used.  
Additionally, all data were assessed using the Grubb’s test for outliers as well as 
descriptive statistics to obtain mean, standard deviation and standard error of the mean.  
Each measure was analyzed separately.  Additionally, a p < 0.05 was considered 
statistically significant. 
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CHAPTER IV 
RESULTS   
Chapter four consists of the results of this descriptive, experimental study.  Data 
regarding the impact of stress on seizure phenotype and behavioral phenotype as well as 
impact of an omega 3 PUFA as a neuroprotectant against abnormal neurological behavior 
are reported.  
RESULTS FROM AIM I 
Purpose: To establish the picrotoxin-induced seizure phenotype of unrestrained as 
well as restrained (stressed) R1648H (RH) mice compared to wild-type (WT) 
littermates (both restrained and unrestrained).   
Hypotheses:  H1: RH mice will have increased frequency and duration as well as 
severity of picrotoxin-induced seizure activity compared to WT mice, H2: Restraint stress 
will increase the frequency and duration as well as worsen the severity of picrotoxin-
induced seizure activity in RH mice and WT mice compared to controls (RH and WT 
unrestrained mice), 
An experimental design of randomly selected RH mice and their wild-type (WT) 
littermates experienced either restraint stress (n = 11 for each genotype) or unrestrained 
conditions (n = 11 for RH mutants, and n = 10 for WT group).  Total numbers in each 
group varied slightly from the original goal of n = 12 in each group due to a few animals 
64 
 
 
 
having complete unresponsiveness to picrotoxin injections.  Each group of mice were 
examined at approximately post-natal day (PND) 90 and weighed on average 25grams.  
There was no difference between the RH mice and their WT littermate’s reaction 
to picrotoxin (5mg/kg) within the first five minutes of dosing.  Baseline data for initial 
reactivity to picrotoxin were compared in Scn1a R1648H mutants (restrained and 
unrestrained) to WT littermates (both restrained and unrestrained).  Both restrained and 
unrestrained mice in the RH and WT mice had similar latency to freezing activity (see 
Figure 9).  This suggests that metabolism of picrotoxin occurred equally between the 
strains.  
Figure 9.  No significant differences in mutants vs. WT in both restrained and 
unrestrained groups within the first five minutes.  One outlier was detected via Grubb’s 
test in the RH no stress group and was removed from the final analysis.   
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Following the first few minutes of injection, RH mutants exhibit increased 
myoclonic jerk frequency in unrestrained conditions.  Compared to unstressed 
(unrestrained) WT littermates, unstressed RH mutants had over four times the number of 
myoclonic jerks per minute (Tukey’s test, p = 0.01, Table 2).  There was no difference in 
myoclonic jerk frequency between restrained groups.  Nor was there a difference in 
latencies to myoclonic jerk between all four groups.  There was a trend towards a 
significance difference among WT littermates between condition of unrestrained and 
restrained (Tukey’s test, p = 0.052) for latency to myoclonic jerk; however, there was no 
difference between condition among mutants (Tukey’s test, p = 0.142).   
RH mutants and WT littermates experiencing restraint stress exhibit decreased 
latencies to partial seizure onset.  To determine the seizure phenotype of RH mutants 
(restrained and unrestrained) compared to their WT littermates, latency to various levels 
of seizures as well as seizure frequency were analyzed.  ANOVA detected main effects of 
restraint stress in regards to latency to focal seizures [F(1,38) = 9.317, p = 0.004], and 
latency to bilateral forelimb clonus [F(1,39) = 12.094, p = 0.001].  While stressed RH 
mutants had significantly decreased latencies to focal seizures (Tukey’s test, p = 0.005) 
and to bilateral forelimb clonus (Tukey’s test, p = 0.012) compared to un-stressed 
mutants, stressed WT littermates (versus un-stressed WT) only had decreased latency to 
bilateral forelimb clonus (Tukey’s test, p = 0.028).  There was no difference between 
mutants and their WT littermates in regards to latencies to partial seizures (either stressed 
or un-stressed) (Table 2).  Surprisingly, there were no differences detected in partial 
seizure frequency between RH mutants and WT littermates.  
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RH mutants experiencing restraint stress exhibit decreased latencies in 
generalized seizures compared to un-stressed RH mutants.  Although there were no 
differences in latency to generalized seizures noted between genotypes, ANOVA did 
detect main effects of stress [F(1,39) = 8.719, p = 0.005].  Post-hoc analysis revealed that 
RH mutants had significantly decreased latency to generalized seizure (Tukey’s test, p = 
0.012, Table 2).  Surprisingly, there was no main effect of genotype or condition or 
interaction effect in regards to total number of generalized seizures or frequency of 
generalized seizures (seizure/minute).  However, a one-way ANOVA was performed to 
more closely examine the frequency of generalized seizures between stressed RH mutants 
and stressed WT group.  Analysis detected a trend in significance between RH mutants 
(6.5  ±1.6) and WT littermates in (2.8  ±1.6) regarding the number of generalized seizures 
(F(1,20) = 4.20,  p = 0.054).  
 
 
 
 
 
 
 
 
 
 
 
 
67 
 
 
 Table 2    Latencies and frequencies of various levels of seizure activity in RH    
mutants and WT littermates receiving IP injections of picrotoxin (5mg/kg) and 
observed for 60 minutes.  Shown is the comparison of mean ± S.E. of latencies to 
myoclonic jerk, focal seizure, bilateral forelimb clonus and generalized seizures as well 
as frequency (seizure per minute) of myoclonic jerk, focal seizure, bilateral forelimb 
clonus and generalized seizure in restrained and unrestrained RH mutants compared to 
restrained and unrestrained WT mice.  Shown is the mean ± S.E of the total number of 
generalized seizures in all four groups.  One outlier was detected via Grubb’s test in the 
WT no stress group and the WT stress group and was removed from the final analysis for 
latency to myoclonic jerk.  One outlier was detected in the WT no stress group and was 
removed from the final analysis for myoclonic jerk frequency.  One outlier was detected 
via Grubb’s test in the WT no stress group and was removed from the final analysis for 
latency to focal seizures.  One outlier was detected via Grubb’s test in the WT stress 
group and was removed from the final analysis for generalized seizure frequency.     
*p < 0.05, ANOVA followed by Tukey’s post-hoc test within condition between RH vs. 
WT 
ª p < 0.05, ANOVA followed by Tukey’s post-hoc test within genotype between 
condition of restraint vs. unrestrained 
ᵇ p = 0.052, ANOVA followed by Tukey’s post-hoc test within genotype 
A
 F(1,20) = 4.20,  p = 0.054, one-way ANOVA, within condition between RH vs. WT 
 Unrestrained (un-stressed) Restrained (stressed) 
Scn1a R1648H WT Scn1a R1648H WT 
Latency to Myoclonic 
Jerk (min) 
6.9  ±0.7 6.6  ±0.8 6.9  ±0.7 5.1  ±0.7 
Latency to Focal 
Seizure (min) 
19.8  ±1.6 18.9  ±1.7 13.2   ±1.6  ª 15.7  ±1.6 
Latency to Bilateral 
Forelimb Clonus (min) 
27.1  ±3.3 28.3  ±3.4 14.9  ±3.3  ª 17.5  ±3.3  ª 
Latency to 
Generalized Seizure 
(min) 
35.9  ±5.1 39.8  ±5.4 16.9  ±5.1  ª 28.2  ±5.1 
Myoclonic Jerk 
Frequency (Jerk/Min) 
1.9  ±0.4  * 0.4  ±0.4 1.1  ±0.4 1.5  ±0.4  ᵇ 
Focal Seizure 
Frequency (Sz/Min) 
1.1  ±0.4 1.4  ±0.4 1.8  ±0.4 1.9  ±0.4 
Bilateral Forelimb 
Clonus Frequency 
(Sz./min) 
0.4  ±0.2 0.7  ±0.2 0.6  ±0.2 0.9  ±0.2 
Generalized Seizure 
Frequency (Sz./min) 
0.1  ±0.03 0.08  ±0.03 0.12  ±0.03 0.07  ±0.03 
Total Number of 
Generalized Seizures 
5.0  ±1.6 3.5  ±1.6 6.5  ±1.6 2.8  ±1.6  A 
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Seizure severity does not differ between RH mutants and WT littermates.  Both 
restrained and unrestrained RH mutants and WT littermates were compared using two-
way ANOVA with no main effect of genotype or condition detected as well as no 
interaction effect noted in total seizure time (Figure 10).  However, when we compared 
each condition (stressed vs. un-stressed) within genotype using an independent t-test, we 
found a trend for significance between RH stressed (26.6 ± 4.4) and RH un-stressed (16.9 
± 2.9) (t (20) = -1.820, p = 0.084) in the total percentage of seizure time.  When we 
compared the RH mutants vs. WT group within condition of stressed (RH 16.921 ± 
2.949, WT 25.848± 5.1, p = .138) as well as unstressed (RH 26.6 ± 4.4, WT 23.3 ± 3.4, p 
= 0.56), there were no trends towards significance noted.  Post-hoc power analysis 
revealed a statistical power of 0.29 in regard to comparing RH stressed vs. RH un-
stressed animals due to insufficient animals in each group; therefore, ongoing 
experiments will augment this sample size.  No differences were detected in level reached 
in the Racine seizure severity scale among the 4 groups (Figure 11).  Additionally, none 
of the groups differed in incidence of long-lasting clonus (status epilepticus) (p = 1.0).   
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Results from Aim II 
Purpose: To establish the behavioral response to stress using multiple behavior 
experiments in the RH mice compared to WT mice. 
Hypotheses: H3: The phenotypic behavioral traits in this model of GEFS+ will parallel 
those traits seen in epileptic humans  
Specific Aim I found that stress worsens the seizure response in RH animals; 
therefore we sought to examine for deficits in response to behavioral paradigms which 
are a natural stressor.  A longitudinal design of randomly selected RH mice and their 
wild-type (WT) littermates experienced a multitude of experiments (n = 12 for each 
genotype) in order to examine the behavioral phenotypes.  Each group of mice were 
examined at approximately post-natal day (PND) 90 and weighed on average 25grams.  
RH mutants exhibit an increased amount of locomotor activity compared to WT 
littermates in the open field experiment.  To perform a more detailed analysis of the 
locomotor activity, multiple measures of total distance travelled and immobility were 
obtained (Table 3).  The RH group had a higher distance travelled in the edge zone when 
compared with their WT littermates (t(21) = -2.787, p = 0.011).  There was no difference in 
total distance travelled in the center zone (p = 0.568) between groups.  However, the RH 
mutants exhibited increased total overall distance travelled (t(21) = -2.649, p = 0.015).   
When analyzing the total time spent in both center and edge zones between RH mutants 
and their WT littermates, there was no difference, and when the speed of both groups was 
compared, the RH mutants displayed a faster average than the WT group (t(21) = -2.665, p 
= 0.014).  This higher speed resulted in the increased total average distance travelled. 
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Conversely, the total time spent immobile (t(21) = 3.867, p < 0.001), and the total number 
of immobile episodes (t(21) =  3.554, p = 0.002) was lower in the RH group.  Sufficient 
power was obtained with alpha > 0.9.  Additionally, not only was the RH group less 
immobile than the WT group, the RH group trended toward significance in that it took 
longer to have their first immobile episode  (t(22) = -2.066, p = 0.051). 
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Table 3   Total locomotor activity measures in RH mutants and WT 
littermates experiencing the Open Field test.  Shown is the comparison of mean ± S.E. 
of the total distance travelled, average speed, immobility measures (total time, number of 
episodes, latency), center measures (total time, number of entries, total distance), edge 
measures (total distance, total time), and fecal boli.  One outlier was detected via Grubb’s 
test in the WT group and was removed from the final analysis for total distance travelled, 
average speed, edge zone distance travelled, and latency to enter center.  One outlier was 
detected via Grubb’s test in the RH group and was removed from the final analysis for 
total time immobile, and latency to enter center. 
 Scn1a R1648H WT 
Total Distance Travelled (meters) 88.9  ±4.2 * 73.3  ±4.1 
Average Speed (cm/sec) 9.9    ±0.5* 8.2  ±0.5 
Total Time Immobile (sec) 107.6    ±6.4 ª 172.8   ±14.9 
Number of Immobile Episodes 27.9    ±2.1 * 40.2  ±2.7 
Latency to Immobility (sec) 58.4   ±10.5 ᵇ 31.1   ±7.9 
Total Time in Center Zone (sec) 62.3  ±10.6 52.1    ±4.4 
Number of Entries to Center Zone 42.5   ±5.6 38.4   ±4.2 
Total Distance Travelled in Center Zone 
(meters) 
9.1   ±1.2 8.2   ±0.9 
Total Distance Travelled in Edge Zone 
(meters) 
79.8  ±3.7 * 65.6   ±3.5 
Total Time in Edge Zone (sec) 837.3   ±10.7 847.3   ±4.5 
Number of Fecal Boli 1.3   ±0.5 1.0   ±0.4 
*p < 0.05, t-test, RH mutant vs. WT 
ª p < 0.001, t-test, RH mutant vs. WT 
ᵇ p = 0.051 t-test, RH mutants vs. WT 
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RH mutants do not demonstrate signs of anxiety-like behavior in the open field 
test compared to WT littermates.  Measures of anxiety in the open field test include time 
spent in the center of the field as well as the number of fecal boli defecated by the animal.  
None of the center measures (total time, total distance, number of entries) were different 
between the RH group and the WT group (Table 3).  Additionally, the number of fecal 
boli was similar between both groups.  
 RH mutants do not demonstrate signs of depressive-like behavior in the forced-
swim test compared to WT littermates.  The forced-swim test is a well-known measure of 
depressive-like behavior or despair (Holmes, 2003).  Figure 12 shows the comparison of 
total time immobile (indicated by floating) between the RH and WT groups for the total 
10 minutes of the test.  There were no significant differences in either the total time 
immobile or the latency to first immobile episode when comparing both groups.   
Figure 12  Total time immobile (seconds) in RH and WT groups.  
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There was a trend for significance to higher total struggling time (sec.) in the RH mutants 
(35.49 ± 8.45) compared to WT littermates (16 ± 5.23) (t(21) = -1.920, p = 0.069); 
however, struggling activity is not indicative of depressive-like behavior.  One outlier 
was detected via Grubb’s test in the WT group and was removed from the final analysis 
for total time struggling.  
RH mutants show no difference in exploratory behavior in the novel cage 
environment test compared to WT littermates.  When comparing the RH mutants with the 
WT group, the only significant difference found was that the RH animals displayed a 
decreased number of immobile episodes (42.00 ± 3.88) compared to WT (55.33 ± 4.38, 
t(21) = 2.263, p = 0.034); however, the total time spent immobile was not different 
between groups (p = 0.752).  Power analysis for total time spent immobile was less than 
desired, therefore we may not have been able to detect a difference in this variable.  Table 
4 describes the variables examined in the paradigm with the RH mutants and their WT 
littermates for the total 15 minutes of time spent in the novel cage.   
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Table 4  Total exploratory activity measures in Scn1a R1648H    mutants and 
WT littermates experiencing the Novel Cage Environment paradigm.  Shown is the 
comparison of mean ± S.E. of the total number of stretch-attends, grooming measures 
(frequency, duration, latency), rearing, burrowing measures (frequency, duration, 
latency), immobility measures (total time, number of episodes), and fecal boli.  One 
outlier was detected via Grubb’s test in the RH group and was removed from the final 
analysis for number of grooming episodes, total time grooming, number of immobile 
episodes, and total time immobile. 
 Scn1a R1648H WT 
Total Number of Stretch-Attends 0.50  ± 0.29 0.75 ± 0.58 
Total Number of Grooming Episodes 16.46  ± 2.99  14.33  ± 1.86 
Grooming Duration (sec.) 18.93  ± 2.74  16.57  ± 1.95 
Grooming Latency (sec.) 64.74  ± 15.38 70.78  ±13.24 
Total Number of Rearing Episodes 122.75  ± 7.75 119.08  ± 7.16 
Total Number of Burrowing Episodes 78.91  ± 8.16 76.08  ± 6.23 
Burrowing Duration (sec.) 71.93  ± 9.55 71.62  ± 6.52 
Burrowing Latency (sec.) 135.21  ± 18.97 158.80  ± 17.22 
Total Time Immobile (sec.) 68.01  ± 6.77  65.28  ± 5.33 
Total Number of Immobile Episodes 42.00  ± 3.88 *  55.33  ± 4.38 
Total Fecal Boli 2.08  ± 0.43 ª 3.59  ± 0.59 
*p < 0.05, t-test, RH mutant vs. WT 
ª p = 0.054 t-test, RH mutants vs. WT 
 
RH and their WT littermates do not have preference for any zone of the Social 
Interaction test box.  Baseline activity in each zone of the Social Interaction test box was 
demonstrated that there was no preference for any zone prior to the addition of a stranger 
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mouse.  No differences were found for either the RH mutants or their WT littermates 
(Figure 13).   
Figure 13 
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RH mutants as well as their WT littermates express sociability behavior in the 
Social Interaction paradigm.  Repeated measures ANOVA revealed a main effect of 
stranger presence (F(1,22) = 18.248, p < 0.001, statistical power = 0.986).  Post-hoc 
analysis found that the RH mutants spent nearly 70% more time (Tukey’s test, p = 0.027) 
and the WT group spent over 50% more time (Tukey’s test, p = 0.001) in the large area 
that housed the stranger mouse (Figure 14) when compared with the empty area.  
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Figure 14       
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Interestingly, the number of entries into this large zone containing the stranger mouse 
was not different between groups or within genotype (Figure 15).   
Figure 15 
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To more closely examine the interaction with the new stranger mouse, we analyzed the 
time spent with the new stranger mouse in a much smaller area surrounding the stranger.  
Repeated measures ANOVA detected a main effect of stranger presence (F(1,22) = 9.45, p 
= 0.006, statistical power > 0.8) on the number of entries in the smaller zone; however, 
post-hoc analysis revealed a significant difference for only the WT group with condition 
(empty 12.33 ± 1.33, stranger side 22.50 ± 1.93, p = 0.008).  ANOVA also detected a 
main effect of stranger presence on the total time spent with the stranger in the small zone 
(F(1,22) = 27.920, p < 0.001, statistical power > 0.9).  Similar to time spent with the 
stranger mouse in the large zone,  post-hoc analysis of the small zone revealed significant 
differences for both RH mutants and their WT littermates in regards to time spent with 
the stranger mouse versus the empty side (Figure 16).   
Figure 16 
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RH mutants express preference for social novelty in the Social Interaction 
paradigm.  Although there was no difference among genotypes in the number of entries 
into the large zone containing the novel stranger mouse versus the older stranger mouse 
(Figure 17), there were significant differences detected in the total time spent with the 
novel mouse (Figure 18) with ANOVA detecting a significant interaction effect (F(1,22) = 
5.009, p = 0.036) of genotype and stranger presence.  Post-hoc analysis revealed that 
there was no difference in the WT group’s interaction with the novel mouse compared to 
the older stranger mouse (p = 0.252); however there was a trend for significant difference 
within the RH group (Tukey’s test, time with old mouse 169.52 ± 16.70 sec. vs. time with 
novel mouse 222.82 ± 14.61, p = 0.06).  Additionally, post-hoc analysis detected a 
significant difference between genotypes for the amount of time spent with the novel 
stranger (Tukey’s test, p = 0.042) (Figure 18).  Interestingly, there was a trend for 
significant difference with total time spent with the older stranger mouse between the RH 
mutants (169.52 ± 16.70 sec.) and their WT littermates (209.85 ± 11.71 sec., p = 0.063) 
(Figure 18). 
 
 
 
 
 
 
80 
 
 
Figure 17 
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Figure 18 
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Again, to more closely examine the interaction of both groups with the novel stranger 
mouse compared to the older, more familiar stranger mouse, we analyzed the total time 
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and number of entries in a much smaller zone surrounding the stranger mice.  Repeated 
measures ANOVA detected an interaction effect of genotype and stranger presence in the 
number of entries into the small zone housing the novel stranger mouse compared with 
the small zone housing the older stranger mouse (F(1,22) = 7.18, p = 0.014) (Figure 19).   
Figure 19 
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Post-hoc analysis revealed that not only was there a significant increase in the number of 
entries into the small zone containing the novel mouse compared to the small zone 
containing the older mouse for the RH mutants (Tukey’s test, 24.16 ± 2.64 vs. 14.91 ± 
2.80 respectively, p = 0.021), but the RH mutants had a significantly higher number of 
entries into the small zone of the novel stranger (24.16 ± 2.64) when compared to the WT 
group (14.66 ± 1.76, p = 0.006).  In addition to the number of entries into the small zone 
housing the stranger mice, we examined the total time spent in these zones for each 
genotype (Figure 20).  Repeated measures ANOVA revealed a significant interaction 
effect of genotype and stranger presence (F(1,22) = 4.969, p = 0.036).  Although there was 
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no significant difference detected within the WT group, the RH mutants spent over 40% 
more time with the novel mouse compared to time spent with the older stranger mouse 
(126.87 ± 12.37 sec. vs. 88.10 ± 10.33 respectively, p = 0.043, Tukey’s test) (Figure 20).  
Interestingly, the RH mutants spent less time with the older stranger mouse (88.10 ± 
10.33 sec.) compared to the WT group (119.88 ± 9.46, p = 0.046, Tukey’s test).   
Figure 20   
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RH mutants express hyperactive behavior compared to their WT littermates in the 
Social Interaction paradigm.  We also examined the total activity of both genotypes and 
found that the RH mutants travelled a significantly longer distance than the WT group 
(120.09 ± 8.55 vs. 95.27 ± 4.67 meters respectively, t (22) = -2.547, p = 0.018).  
Additionally, the RH group travelled at a faster speed than their WT littermates (20.0 ± 
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1.42 cm/sec vs. 15.87 ± 0.77 cm/sec., t (22) = -2.545, p = 0.018).  Lastly, the immobility in 
the RH mutants was diminished by 50% compared to the WT group (t (22) = 3.524, p = 
0.002) (Figure 21).  
Figure 21 
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RH mutants and their WT littermates exhibit fear response in the presence of a 
predator odor.  One way to assess the potential fear response of a rodent is to observe the 
freezing behavior during presence of a predator odor compared to the freezing response 
before and after the presence of the odor.  Repeated measures ANOVA detected a main 
effect of genotype (F(1,18) = 6.381, p = 0.021) as well as a main effect of presence of odor 
(F(2,36) = 44.201, p < 0.001) on the number of freezing episodes; however, there was no 
significant interaction effect found (p = .201).  Through post-hoc analysis, baseline data 
for day one of the predator odor experiment (before odor) revealed no significant 
difference in the number of freezing episodes between the RH group and their WT 
littermates (Tukey’s test, p = 0.35) (Figure 22).  And while there was a significant 
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increase within genotype for the number of freezing episodes between all conditions (p < 
0.05 for all conditions within genotype), there was significantly fewer number of freezing 
episodes between the RH mutants and WT group in day three of the experiment (presence 
of odor) (61.40  ± 10.30 vs. 103.50 ± 11.65 respectively, p = 0.016, Tukey’s test) and in 
day 5 of the experiment (after odor) (92.50 ± 12.98 vs. 136.20 ± 17.81, p = 0.013, 
Tukey’s test) (Figure 22).  
Figure 22 
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We also analyzed the total amount of time spent freezing in the before odor, 
during odor and after odor conditions for both the RH mutants and the WT group.  There 
was a significant main effect of genotype (F(1,17) = 5.112, p = 0.037) and condition (F(2,34) 
= 23.871, p < 0.001); however there was no interaction effect (F(2,34) = 2.845, p = 0.072) 
(Figure 23).  Through post-hoc analysis, it appears that there is no significant difference 
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between the RH mutants and WT group in total freezing time within the first day of the 
paradigm (before odor).  There is over 1.5 times less freezing in the mutants compared to 
the WT group on day 3 (odor) (54.68  ± 12.41 vs. 93.667 ± 12.708 respectively); 
however there is only a trend for significance between these data (p = 0.064, Tukey’s 
test).  On day 5 (after odor), the RH mutants and WT group do differ significantly (79.47 
± 13.70 vs. 139.233 ± 27.907 respectively, p = 0.006, Tukey’s test) (Figure 23).  It was 
also noted that the WT group had significantly increased total freezing time between all 
conditions of before odor, odor, and after odor (p < 0.05 between all conditions).  
Interestingly, despite having a significantly increased number of freezing episodes 
between all conditions, the RH mutants did not have increased total freezing time 
between day 1 (before odor) and day 3 (odor) (24.85  ± 3.41  vs. 54.68  ± 12.41 
respectively,  p = 0.186, Tukey’s test).  Nor did the RH group have significantly 
increased freezing time between day 3 (odor) and day 5 (after odor) (54.68  ± 12.41 vs. 
79.47 ± 13.70 respectively, p = 0.307, Tukey’s test).  Post-hoc analysis did reveal a 
significant increase in total freezing time for the RH mutants from day 1 (before odor) 
compared to day 5 (after odor) (24.85  ± 3.41  vs. 79.47 ± 13.70, p = 0.007, Tukey’s test). 
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Figure 23   
One outlier was detected via Grubb’s test in the RH group and was removed from the 
final analysis for total freezing time. 
 
 
 
 
 
 
 
 
 
RH mutants and their WT littermates exhibit anxiety-like behavior in the Predator 
Odor paradigm.  Anxiety-like behavior can potentially be interpreted when in a decrease 
in normal exploratory behavior in a rodent (Holmes, 2003).  The exploratory activity of 
rearing was observed and analyzed with repeated measures ANOVA and found that while 
there was no significant main effect of genotype (p = 0.204), there was a significant main 
effect of the condition of odor presence (F(2,34) = 61.944, p < 0.001, statistical power > 
0.9).  No interaction effect was found (F(2,34) = 1.006, p = 0.376). We examined the 
number of times the animals displayed rearing activity and found a significantly 
decreased number of rears within both the RH mutants (198 ± 13.116 vs. 144.0  ± 12.70, 
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p < 0.001) and the WT group (185.70  ± 10.35 vs. 113.70 ± 8.98,  p < 0.001) from before 
odor to the presence of odor (Figure 24).  And while both RH mutants and their WT 
littermates had significantly decreased number of rears from the condition of before odor 
to after odor as well (both p < 0.001), there was no significant difference for either 
genotype in the number of rears from odor presence to after odor presence (both groups p 
> 0.05) (Figure 24).  Interestingly, there was only a trend for significant difference 
between genotypes during odor presence between the RH mutants (144.0  ± 12.70) and 
the WT group (113.70 ± 8.98, p = 0.071, Tukey’s test) (Figure 24).  There were no 
significant differences noted in the number of fecal boli from either group between or 
within any condition.   
Figure 24  One outlier was detected via Grubb’s test in the WT group and was removed 
from the final analysis for total number of rearing episodes. 
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Results from Aim III 
Purpose: Determine the neuroprotective effects of subcutaneous injections of 
docosahexaenoic acid (an omega 3 PUFA) on hyperactive behavior in RH mice. 
Hypothesis: H4: Administration of omega 3 PUFA’s to the Scn1aR1648H mice will lead to 
a reduction in perturbed behavioral traits 
Because Specific Aim II noted clear and consistent evidence of hyperactive 
behavior, a longitudinal design of randomly selected RH mice and their wild-type (WT) 
littermates experienced SQ injections of either DHA 100mg/kg or vehicle (oleic acid 
100mg/kg) or no injections.  Each group of mice were examined at approximately post-
natal day (PND) 35 and weighed on average 18 grams.  The initial goal for the number of 
animals in this experiment was 10 in each group for a total of 60 animals.  Because of the 
number of animals born in each litter, randomization to each group, and animal morbidity 
during experimentation, we ended up with WT unhandled controls (n = 17), WT with 
DHA injections (n = 12), WT with OA injections (n = 12), RH unhandled controls (n = 
14), RH with DHA injections (n = 10), and RH with OA injections (n = 10).  
RH mutants and their WT littermates receiving DHA (100mg/kg) SQ or Oleic 
Acid (100mg/kg) daily for two weeks starting at weaning had reduced locomotor activity 
compared to unhandled controls.  Two-way ANOVA detected a significant main effect 
of genotype (F(1,69) = 10.27, p = 0.002, statistical power > 0.8) and condition (F(2,69) = 
19.45, p < 0.001, statistical power > 0.8) with no interaction effect regarding the total 
distance travelled in the open field paradigm (see Table  5).  Tukey’s post-hoc analysis 
revealed that RH mutants receiving either DHA or OA had reduced distance travelled 
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compared with RH unhandled controls (p < 0.01).  Tukey’s post-hoc analysis also 
revealed that WT’s receiving either DHA or OA had reduced distance travelled compared 
with WT unhandled controls (p < 0.01).  RH mutants receiving DHA travelled a farther 
distance than WT’s receiving DHA (p = 0.028).  Additionally, there was a trend for 
significance difference for unhandled RH mutants travelling farther than unhandled WT 
(p = 0.054).  Interestingly, there was no difference in the OA group for RH vs. WT (p = 
0.174).   
Two-way ANOVA also detected a significant main effect of genotype (F(1,69) = 
10.22, p = 0.002, statistical power > 0.8) and condition (F(2,69) = 19.49, p < 0.001, 
statistical power > 0.8) with no interaction effect regarding the average speed in the open 
field paradigm (see Table  5).  Tukey’s post-hoc analysis revealed that RH mutants 
receiving either DHA or OA travelled at a slower speed compared to the RH unhandled 
controls (p < 0.01).  Tukey’s post-hoc analysis also revealed that WT’s receiving either 
DHA or OA travelled at a slower speed compared to the WT unhandled controls (p < 
0.01).  RH mutants receiving DHA travelled faster than WT receiving DHA (p < 0.05), 
and there was a trend for significance for RH unhandled controls travelling faster than 
WT unhandled controls (p = 0.054).   
Two-way ANOVA also detected a significant main effect of genotype (F(1,68) = 
14.02, p < 0.001, statistical power > 0.8) and condition (F(2,68) = 19.17, p < 0.001, 
statistical power > 0.8) with no interaction effect regarding the total time immobile in the 
open field paradigm (see Table  5).  Tukey’s post-hoc analysis revealed that RH mutants 
receiving OA had increased immobility compared to the RH unhandled controls (p < 
0.01).  There was a trend for significance for RH mutants receiving DHA to have 
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increased immobility compared to RH unhandled controls (p = 0.078).  Tukey’s post-hoc 
analysis also revealed that WT’s receiving either DHA or OA had increased immobility 
compared to the WT unhandled controls (p < 0.01).  RH mutants receiving DHA had 
reduced immobility compared to WT receiving DHA (p = 0.002), and there was a trend 
for significance for RH receiving OA to have reduced immobility compared to WT 
receiving OA (p = 0.084).  RH unhandled controls did not differ from WT unhandled 
controls in total time immobile (p = 0.201).  Conversely, RH unhandled controls did have 
reduced number of immobile episodes compared to WT unhandled controls (p = 0.048).  
Two-way ANOVA also detected a significant main effect of genotype (F(1,67) = 8.417, p 
= 0.005, statistical power = 0.777) and condition (F(2,67) = 2.45, p < 0.001, statistical 
power > 0.8) with no interaction effect regarding the total number of immobile episodes 
in the open field paradigm (see Table  5).  Tukey’s post-hoc analysis revealed that RH 
mutants receiving DHA or OA had increased number of immobile episodes compared to 
the RH unhandled controls (p < 0.01).  Tukey’s also revealed that WT’s receiving DHA 
or OA had increased number of immobile episodes compared to WT unhandled controls 
(p < 0.01). 
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Table 5   Total locomotor activity measures in RH mutants and WT littermates 
experiencing the Open Field test during the omega 3 Trial.  Shown is the comparison 
of mean ± S.E. of the total distance travelled, average speed, immobility measures (total 
time, number of episodes).  One outlier was detected via Grubb’s test in the WT group 
(unhandled) and was removed from the final analysis for total time immobile and number 
of immobile episodes.  One outlier was detected via Grubb’s test in the WT group (OA) 
and was removed from the final analysis for total number of immobile episodes.  
* p < 0.01 within genotype compared to Control 
b p < 0.05 within condition  Het vs. WT 
+ 
 p = 0.078 trend within genotype compared to Control 
a p = 0.054   within condition  Het vs. WT 
 
In this chapter, the results of a descriptive, experimental study were presented to 
illustrate findings using an animal model of GEFS+.  The picrotoxin-induced seizure 
phenotype of unrestrained as well as restrained (stressed) animals was described.  
Additionally, the behavioral phenotypes using multiple experimental paradigms (open 
field test, forced swim test, novel cage environment test, social interaction test, and 
   Unhandled Controls  DHA  OA  
RH WT  RH WT  RH    WT  
Total Distance 
Travelled (m)  
72.94 ± 
4.39 
63.62   ± 
3.82  
54.77    ± 
2.88  * b 
42.09   ± 
3.12  * 
53.33   ± 
4.21  * 
45.59  ± 
2.55 * 
Average Speed 
(m/sec)  
0.086   ± 
0.0052  a 
0.075± 
0.004 
0.065 ± 
0.003  * b 
0.05            
± 0.0037   * 
0.063  ± 
0.005  * 
0.054          
± 0.003  
* 
Total Time 
Immobile (sec)  
123.47   ± 
15.96  a 
157.78 ± 
14.90 
189.7   ± 
24.75
  b  +
 
293.22        
± 25.75 * 
225.35 ± 
23.82  * 
279.83       
± 22.18  
* 
Total Number of 
Immobile Episodes 
25.64  ±   
2.43  b 
31.81  ± 
2.11 
38.40 ±    
3.06 * b 
47.16 ±   
1.87  * 
43.00  ±   
3.16  * 
45.36  ±  
1.73  * 
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predator odor test) were explored and described.  Lastly, the impact of DHA, an Omega 3 
PUFA, after weaning as neuroprotection for the RH mouse against hyperactivity was also 
presented.   
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CHAPTER V 
DISCUSSION 
Chapter five presents a discussion of the study results and provides insight for 
nursing practice.  This chapter will also discuss the strengths and limitations of the study. 
Study conclusions will provide future recommendations for research.  This study reports 
that stress worsens the seizure phenotype in animals with an Scn1a mutation 
recapitulating GEFS+.  This study is also the first to report hyperactive locomotor 
behavior in a mouse model of GEFS+.  Better understanding of seizure and behavioral 
phenotypes in this disorder will help to guide improved treatment and prevention of the 
primary disease as well as co-morbid conditions.  
Stress is reported to increase the severity and frequency of seizure activity 
(Bosnjak et al., 2002; Forcelli et al., 2007; Swinkels et al., 1998); however, there is still a 
scarcity of information regarding GEFS+ and the impact of stressful events.  
Additionally, the seizure phenotype of GEFS+ is reported as having a high degree of 
seizure variability (Mahoney et al., 2009), and information regarding specific behaviors 
such as depression and anxiety is lacking.  There is an even greater lack of knowledge in 
the effects of omega 3 PUFA’s in regards to neurological deficits in those with epilepsy.  
This study adds to the body of knowledge of seizure and behavioral phenotypes of 
persons with GEFS+ as well as the impact of omega 3 PUFA’s on neurological deficits.   
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Seizure Phenotype in Stressed and Unstressed RH Mutants and WT Littermates 
The first aim of this study was to describe the picrotoxin-induced seizure 
phenotype in stressed and unstressed animals with the RH mutation.  Using restraint 
stress on male animals approximately 90 days old we noted differences in seizure 
phenotype between RH mutants and their WT littermates, and that the stressful 
experience impacted the seizure phenotype in both groups.   
In any experimental paradigm, it is import to ensure the validity of results through 
rigorous control of independent variables.  A mouse can experience stress during simple 
handling and housing (Longordo, Fan, Steimer, Kopp, & Lthi, 2011).  Because the effects 
of restraint stress on seizure phenotype were explored, the experimental protocol used 
every effort to reduced extraneous stressful events.  The animals were single-housed and 
maintained in standard housing with water and rodent chow available ad libitum one 
week prior to all testing.  Additionally, all tests were performed in the morning between 
the hours of 0900 and 1200.  This helped to maintain consistency and control for any 
hormonal or circadian changes (Moura, Gimenes-Jnior, Valentinuzzi, & Xavier, 2009; 
Roedel, Storch, Holsboer, & Ohl, 2006).  During experimentation, the room was quiet 
and controlled for environmental conditions that may induce stress such as temperature 
and light changes (Bailey & Crawley, 2009).  On the morning of the test, the animals 
were moved to the experimental room two hours prior to testing to allow for acclimation 
to the new environment and cage movement.  For the behavioral paradigms, a variety of 
tests were used to determine if a behavior was observed in multiple experiments.  Any 
behavior that was able to be scored using computerized software was done so, and all 
other behaviors were scored by the same researcher.   
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The baseline data for initial responsivity to picrotoxin are important to note 
because this demonstrates that mice in all four groups had the same initial reaction time 
to picrotoxin.  This allows for future comparisons of seizure latency and activity and 
indicates that picrotoxin is metabolized equally among all the groups.  If the mutants had 
initially responded earlier or later than their WT littermates, comparisons of other 
latencies would be difficult. 
The results of increased seizure activity under stressful conditions in this model of 
GEFS+ are similar with reports of elevated seizure activity associated with stress in other 
epileptic disorders (Bosnjak et al., 2002; Forcelli et al., 2007; Swinkels et al., 1998).  One 
reason for this could be because corticosterone is released during a stressful event and 
affects the function of voltage-gated ion channels (Brunson et al., 2002; de Kloet et al., 
2005).  Obtaining serum corticosterone levels would be important for comparison in the 
stressed and un-stressed animals and should be collected in future studies using this 
model.  Both the RH mutants and the WT group had worse seizure phenotypes in 
response to stress; however, it appears as if restrained (thus stressed) RH mutants have a 
stronger reaction.  This study helps to validate that a genetically engineered mouse model 
of a human disease shows many of the same traits found in humans with similar 
conditions.  Through this study, we have now provided evidence for strategies to help 
reduce morbidity of disease as well as address complaints found in humans. 
Picrotoxin, used to induce epileptogenesis in this study, blocks GABAA receptors 
(Hill, Simmonds, & Straughan, 1972).  Because the R1648H as well as other missense 
mutations on the SCN1A gene are reported to cause reduced inhibition of GABAergic 
interneurons (Hawkins et al., 2011; Martin et al., 2010; Ohno et al., 2010), picrotoxin 
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should be effective in inducing increased seizure activity in animals with this genetic 
mutation compared to animals without this mutation.  However, few researchers have 
used this agent for epileptogenesis in experimental paradigms involving animals with 
sodium channel mutations.  The Escayg lab reports using kainic acid (Martin et al., 2010; 
Tang et al., 2009) or flurothyl (Martin et al., 2010) to examine induced seizure activity in 
animals with this particular mutation.  Perhaps using another pro-convulsant that acts on 
GABA receptors would be useful in determining if similar results would be found.   
 Behavioral Phenotype in RH Mutants and WT Littermates 
 The second aim of this study was to examine the behavioral phenotypes in mice 
with the RH mutation.  RH mutants underwent various behavioral paradigms to elucidate 
differing behaviors, if any, from their WT littermates.  Through multiple paradigms, a 
clear and consistent evidence of hyperactive behavior exhibited by the RH mutants was 
found.   
Hyperactivity  
In both the open field and social interaction paradigms, the adult mutants travelled 
a greater distance and exhibited less immobility.  Additionally, their speed was 
significantly greater.  These data were also found in ‘adolescent’ animals (PND 35 is 
considered adolescence in mice).  In the forced-swim test, the trend for increased 
struggling behavior in the RH mutants may also be due to hyperactivity.  Hyperactive 
behavior and sodium channel mutations has rarely been examined, although multiple 
studies have associated childhood epilepsy with ADHD (Cohen et al., 2012; Ottman et 
al., 2011; Russ et al., 2012).  Brunklaus and colleagues (2011) did report that in 163 
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children with Dravet syndrome (the severe end of the GEFS+ spectrum of disorders) 
there was a 66% prevalence of hyperactive behavior which is starkly contrasted with the 
average national prevalence of ADHD of 8% (Bloom et al., 2009).  The only other 
evidence is found in a case report of a child with extended spectrum GEFS+ which is 
considered more on the severe end of the spectrum of GEFS+ (Grant & Vazquez, 2005). 
The current study’s novel finding of hyperactivity in an animal model of GEFS+ will 
help inform the medical community of further assessment needed for individuals with 
GEFS+.  
Gamma (γ)-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in 
the brain and is released as needed to inhibit pyramidal neurons (excitatory), other 
neurons that influence pyramidal neurons, or other GABAergic neurons (Tamminga et 
al., 2004) and is believed to be play a part in the reduced inhibitory control seen in 
ADHD.  Because the prefrontal cortex (PFC) is considered to be the main area of the 
brain responsible for control of behaviors that are altered in ADHD (Brennan & Arnsten, 
2008), several animal studies have examined the alterations in locomotor activity when 
GABA is either suppressed (increasing locomotor activity) or increased (reversal of 
hyperactive behavior) in this region (Del Arco et al., 2011; Enomoto et al., 2011; 
Lecourtier et al., 2010).  A human study examined the GABA concentration in the brains 
of children age 8-12 year-olds with confirmed diagnosis of ADHD (n = 13) and found 
reduced concentrations when compared with matched healthy controls (n = 19) (Edden, 
Crocetti, Zhu, Gilbert, & Mostofsky, 2012).  The R1648H missense mutation on the 
SCN1A gene specifically alters GABAergic interneurons (Martin et al., 2010); therefore 
we infer that GABAergic interneurons in the PFC are also impacted which may explain 
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the consistent evidence of increased locomotor activity found in the current study.  This 
is a novel finding.  Children with GEFS+ experience a variety of other physiological 
problems such as learning deficits, behavioral problems, neuropsychiatric disorders and 
developmental delay (Mahoney et al., 2009); however hyperactive behavior associated 
with GEFS+ (except in more severe cases) is not reported in the literature.  It could be 
that this has not been an area of focus or that larger, epidemiological studies have not 
been conducted to assess other physiological or neurological deficits in this population.  
The novel finding of hyperactivity in the current study will help to guide future studies to 
specifically assess this behavior in persons with GEFS+.  This is a critical component of 
assessment because hyperactivity (as well as inattention) is a strong predictor of poor 
health-related quality of life (Brunklaus et al., 2011). 
Anxiety, Depression, Social Isolation 
In the current study, none of the measures of anxiety-like behaviors revealed any 
differences.  However, it is important to note that decreased distanced travelled and 
decreased speed in rodents may also indicate fear/anxiety (Holmes, 2003).  Because the 
RH mutants in this study exhibited an increased level of locomotor activity in regards to 
distance travelled, speed of travel and time spent freezing, we speculate that these 
animals might indeed have anxiety-like behavior.  Within the novel cage paradigm, the 
typical levels of anxiety (grooming, burrowing, and rearing) were not different between 
groups; however, we speculate that a mouse exhibiting hyperactive locomotion may also 
potentially display other increased activities such as rearing.  Because the RH mutants’ 
baseline locomotor activity level is ‘hyperactive’, we might expect increased levels of 
activity in their grooming, burrowing and rearing behavior.  We found that these 
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exploratory behaviors were similar between RH mutants and their WT littermates 
suggesting that these exploratory behaviors were indeed reduced in the RH mutants due 
to baseline differences compared to the WT group.  It would be important to use other 
experimental paradigms to measure anxiety that do not rely on locomotor activity 
(Holmes, 2003) such as the startle response test (Curzon, Zhang, Radek, & Fox 2009).  
The RH mutants in the current study did not exhibit any differences in floating 
behavior compared to their WT littermates, suggesting a lack of depressive behavior 
associated with this particular mutation.  However, there was a trend for significance of 
increased struggling behavior in the RH mutants (p = 0.069).  We speculate that this 
could also be a manifestation of hyperactive locomotor activity.  
Social interaction was assessed using a paradigm that examined sociability as well 
as preference for social novelty.  Mice are typically social animals and prefer to explore 
new animals within their environment (Bailey & Crawley, 2009).  Both the RH mutants 
and their WT littermates in the current study displayed sociability, meaning that they 
explored a new animal introduced into their environment.  Interestingly, the RH mutants 
also displayed preference for social novelty, which means that when a second new animal 
(10 minutes after the first new animal was introduced) was placed into their environment, 
they preferred to explore the newest animal; however, their WT littermates did not have 
preference for social novelty.  The lack of preference for social novelty could be due to 
the specific breed of mouse used in this study.  C57BL/6J mice were reported to lack 
preference for social novelty in the three chamber social box test when they either 
encountered their own strain or another strain of mouse (Pearson, Defensor, Blanchard, & 
Blanchard, 2010).  The fact that the RH mutants did show preference for social novelty, 
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even though they are C57BL/6J strain, indicates that possibly the Scn1a mutation 
somehow enhanced this preference.  It is important to note that during the experimental 
paradigm, the test mouse was not removed and replaced in the center of the three 
chambered box when each stranger mouse was introduced which could have altered the 
time spent in any of the chambers depending in which chamber the test mouse was 
standing.  Future studies will include repeating this paradigm and removing the test 
mouse during each phase of the experiment to ensure they are starting each phase in the 
center of the test box.   
 Conditioned Memory 
 Both RH mutants and their WT littermates exhibited significantly more freezing 
and reduced rearing frequencies when they were faced with predator odor compared to 
the first episode of no odor.  However, they continued to exhibit increased freezing and 
reduced rearing when placed in the same type of container without the predator odor for 
the second time.  This may represent conditioned memory of fear for the odor in these 
mice.  It could be that this breed of mouse has a general affinity for conditioned fear 
response.  C57BL/6J mice experienced conditioned fear response when experiencing 
cues (either auditory and/or footshock) and contextual changes (new environment 
associated with the cues) (André, Cordero, & Gould, 2012; Paylor, Tracy, Wehner, & 
Rudy, 1994).  Therefore we are suggesting the findings in the current study may be due to 
animal strain.  
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Implications for SCN1A  
 The model used in the current study used a missense mutation on the Scn1a gene.  
As stated earlier, SCN1A dysfunction mainly impacts GABAergic interneurons (Martin 
et al., 2010).  Dysfunction in GABAergic interneurons is also associated with 
schizophrenia and autism (Chattopadhyaya & Di Cristo, 2012).  Findings from this study 
may extend beyond GEFS+ in that we may also be able to apply the findings to other 
disorders with SCN1A or known GABAergic dysfunction.  In addition, it may be that 
genetic variants affecting SCN1A, but not necessarily in epilepsy, may contribute to 
hyperactivity.  This could mean that SCN1A is a candidate gene for hyperactivity.  Han 
and associates report hyperactivity in their Scn1a knock-out mouse (Han et al., 2012) 
which further implicates SCN1A and GABAergic dysfunction in hyperactive behavior.  
Neuroprotection Using DHA 
Lastly, we wanted to determine if the daily administration of DHA, an omega 3 
polyunsaturated fatty acid (PUFA), could provide neuroprotection to the RH mouse 
against the deficits that we found in the behavioral paradigms.  Results show that 
subcutaneous injection of DHA 100mg/kg daily for two weeks after weaning [this time 
period corresponds to adolescence in humans (Crawley, 2000)] did not significantly alter 
locomotor hyperactivity in RH mutants compared to controls receiving injection of oleic 
acid 100mg/kg.  The reason for the lack of effectiveness could be due to multiple factors.  
First, the optimal effective dose of DHA is not understood and varies greatly in human 
studies (Bloch & Qawasmi, 2011; Ortega, Rodríguez-Rodríguez, & López-Sobaler, 
2012).  The dose of 100mg/kg was chosen based on the desire to avoid local injection site 
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irritation but hopefully provide enough DHA to confer neuroprotection.  Future studies 
will use various doses, correlated with serum and brain levels, to assess efficacy against 
hyperactive locomotion.  Second, the length of time of administration may have been 
inadequate.  Future studies will also use longer time periods before assessing levels of 
locomotor activity.  We noted that RH and WT controls injected with vehicle (oleic acid) 
had reduced levels of activity similar to the RH mutants and WT’s injected with DHA 
respectively.  Additionally, animals in both groups (injected either with DHA or OA) had 
similar improvements in their deficits compared to the unhandled controls within the 
same genotype.  The act of daily injections involves a certain amount of handling of the 
animals which could have led to the animals becoming accustomed to a new or stressful 
(such as that of being placed in an open field) event thereby reducing locomotion by 
reducing fear.  This is only a postulation because we do not know if the animals exhibit 
increased locomotor activity because of innate hyperactivity or because of anxiety in 
stressful situations.  
Implications for Nursing Practice  
The main goal of nursing care is to reduce and prevent disease morbidity, and 
knowledge gained from the current study will guide clinical nursing practice as well as 
nursing research.  Nurses assess patients with epilepsy in a variety of settings including 
hospitals, outpatient clinics, and community settings (health setting as well as home 
setting).  As nurses constitute the largest group of healthcare providers in the United 
States, our time spent with patients in assessing and evaluating outcomes can guide the 
direction of care.  Providing evidence-based nursing practice helps to ensure that quality 
patient care is received (http://www.nursingworld.org/EspeciallyForYou/Nurse-
103 
 
 
Researchers), disease and disability are prevented as well as improving symptoms related 
to illnesses (http://www.ninr.nih.gov/).  The current study provides evidence that this 
genetically engineered mouse model of a human disease shows many of the same traits 
found in humans with similar conditions.  Through this study, we have now provided 
support for strategies to initiate treatment of disease as well as address complaints found 
in humans.  While the seizure phenotype of GEFS+ has been discussed in the literature, 
the impact of stress within this condition, as well as the behavioral phenotypes, has 
largely remained unexplored.  Nurses will be able to use information gained from this 
study to focus on specific behavioral assessments in children with this genetic disorder.  
ADHD consists of the impairment of attention as well as increased locomotor activity 
and is associated with multiple problems such as poorer quality of life (Brunklaus et al., 
2011) and school performance (Diamantopoulou et al., 2007) as well as increased drug 
addiction (Falck et al., 2008) and criminal behavior (Langley et al., 2010).  Thorough 
behavioral assessment may lead to treatment of this symptom thus improving quality of 
life (Cannon et al., 2009; Wehmeier et al., 2007).  Additionally, acute stress management 
appears to be important in those with GEFS+ as it is in other epilepsy conditions 
(http://www.bcepilepsy.com/files/Information_Sheets/Stress_Management.pdf; 
http://www.epilepsy.com/epilepsy/provoke_stress).  Because experiencing stressors is 
such a common occurrence in our current society, identifying the effects of stress on 
behavior helps add to the body of knowledge regarding manifestations of stress, 
specifically in those with GEFS+.  Nurses can provide education regarding recognition of 
stressful events as well as stress management techniques such as relaxation, distraction or 
meditation (Varvogli & Darviri, 2011).  
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This study also adds to the body of literature regarding the role of genetics in 
human conditions.  Integrating genetics into nursing practice allows the nurse to 
incorporate a more wholistic approach to patient care and become a full partner in 
collaboration with other healthcare providers that are using genetics as part of everyday 
practice (Seal, 2011).  Nurses use knowledge of genetics when conducting a thorough 
medical and multi-generational family history which can help identify patients at risk for 
neurological disorders or those with neurological injury.  Early interventions and 
preventative measures are key to reducing and relieving disease morbidity.  Once needs 
or risks are identified, it is the nurse’s responsibility to educate patients on their 
modifiable risk factors.  
While advanced-practice nurses can initiate pharmacological treatments and 
nurses administer these treatments in healthcare settings, many non-pharmacological 
therapies can be effective with a wide variety of disorders and symptoms.  However it is 
crucial to make knowledgeable recommendations of complimentary therapies based on 
scientific research.  Although omega 3 PUFA’s are effective in mitigating some cardiac 
dysfunction (Mozaffarian & Wu, 2011), their impact on neurological disorders and 
dysfunction is still being investigated.  Understanding how these fatty acids can improve 
neuronal cell signaling will guide nurses in educating patients on the potential mechanism 
of action of n-3 PUFA’s that can benefit patients with epilepsy and co-morbid 
neurological disorders.  
Nursing research is also needed in the area of omega 3 PUFA’s and neurological 
disorders.  Understanding how the brain is impacted by essential fatty acids is crucial in 
directing appropriate treatment but can also help in prevention of disorders.  Sometimes 
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healthcare providers focus on treating symptoms when prevention could have occurred.  
Nurses should be proactive with their patients in promoting and maintaining health.  
Research helps guide our knowledge so that we can thoroughly assess, treat and educate 
patients.   
Strengths and Weaknesses of Study 
The main strength of this study is that the animal model recapitulates the human 
condition of GEFS+.  The animals were generated in order to have the human genetic 
mutation of R1648H on the Scn1a gene.  This helps to ensure that data collected from 
these animals closely resemble outcomes in humans.  Some seizure or behavioral 
characteristics cannot be experimentally examined in humans; therefore, this animal 
model is ideal for examining seizure and behavioral phenotypes.  The strengths of this 
study also include maintaining control of the environment and experimental design.  
Using an animal model of a human condition allows the researcher to focus on the main 
variable (in this case the R1648H missense mutation) with otherwise very little 
heterogeneity between subjects.  Additionally, all experiments are conducted with the 
same age of animal and during the same time of day to remove circadian influences.  
Confounding environmental factors play only a minute role in laboratory research.  This 
means that while every effort is made to maintain environmental control (noise, odors, 
and stressors) and use the same experimental procedures with every animal, the 
researcher will never be able to eliminate all possible sources of confounders.  
Nevertheless, laboratory research provides a good source of control over extraneous 
variables.  Next, internal consistency was maintained by using the same researcher to 
conduct the experiments as well as recording and analyzing the data.  This means that 
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interpretation of data (i.e., partial seizure vs. a myoclonic jerk, or struggling vs. floating) 
was consistent throughout the study.  Inter-rater reliability was ascertained by having 
another researcher code some of the data and compare with primary researcher.  Another 
strength is that, when appropriate, animals were randomly assigned to experimental 
groups and the primary researcher was blinded to genotype in all experiments except for 
the omega 3 PUFA trial in which the primary researcher was required to know genotype 
to appropriately assign animals to experimental groups (once genotype was determined, 
the animals were still randomly assigned).  
Understanding the neurological pathways that are impacted in those with SCN1A 
mutations helped to guide the use of the pharmacological as well as non-pharmacological 
agents in this study.  For example, picrotoxin is a GABAA receptor antagonist (Bast, 
Zhang, & Feldon, 2001).  Because SCN1A mutations are known to highly impact 
GABAergic interneurons (Martin et al., 2010), using this proconvulsant specifically 
targeted those pathways.  Additionally, DHA is known to impact cell signaling and is 
reported to improve [3H]-muscimol (analogous to GABA) binding to GABAA receptors 
(Sogaard et al., 2006) which provided rationale for use in this study.  
To our knowledge, this is the first study to examine the effects of acute stress on 
seizure activity as well as behavioral characteristics in an animal model resembling the 
human condition of GEFS+.  Additionally, no studies have examined the impact of DHA 
on hyperactivity in these animals.  When studying behavioral characteristics, especially 
using animal models, it is important to replicate results using various experimental 
paradigms.  This study found hyperactive locomotor behavior within two paradigms 
which provides clear and consistent evidence of this abnormal behavior.  
107 
 
 
The weaknesses of this study are also important to discuss.  While adequate 
power was obtained in many of the dependent variables, some of the data analysis 
revealed inadequate power which is important to determine significant differences.  In 
animal research it is crucial to use as few subjects as possible to promote conservation of 
animals; however it is just as important to utilize enough animals to maintain adequate 
power so that results can be interpreted correctly.  Future research will include a few 
more animals to obtain power of at least 0.8 in paradigms in which adequate power was 
not attained.  Another weakness of the study was in the experimental design of the social 
interaction test.  There are three phases in this paradigm.  In the first phase, the animal is 
placed in the center of the empty social interaction box.  In phase two, a conspecific 
‘stranger’ mouse is placed in one of the corners, and in phase three, another conspecific 
‘stranger’ mouse is placed in the other corner.  For this study, the test mouse was not 
removed and replaced in the center of the box during the beginning of phases two or 
three.  Placing the mouse in the center of the box during the beginning all three phases 
would have ensured consistency of the starting point of the test mouse when each 
stranger mouse was introduced.  
A third weakness of the study was in regard to the dependent variable of anxiety.  
In the novel cage experiment, the animals were examined for exploration behavior (i.e., 
grooming, burrowing, and rearing).  Because these animals display a clear and consistent 
behavior of increased locomotor activity, it is difficult to interpret the data from the novel 
cage.  If the baseline locomotor behavior of the RH mutants is ‘hyperactive’, then other 
measures of movement such as burrowing and rearing may be confounded by the 
increased locomotion.  
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Recommendations for Future Research 
 Future recommendations of the study include additions or alterations to the 
experimental design.  First, another agent to induce epileptogenesis should be used.  
Although picrotoxin is a GABAA antagonist, the effects of this drug was not clear and 
consistent between RH mutants and their WT littermates.  Flurothyl has been used in 
animal models of epilepsy, specifically with animals with sodium channel mutations 
(Martin et al., 2007; Martin et al., 2010), to examine seizure latencies.  Flurothyl also acts 
on GABAergic interneurons and would be appropriate to use with this animal model of 
GEFS+.  
 The weaknesses of the social interaction test were discussed earlier; therefore this 
experiment should be repeated to make sure the test animal is removed and replaced in 
the center of the box at the beginning of each phase when the new stranger mouse is 
introduced.  Other changes in the experimental paradigm include adding more animals to 
the open field experiment to ensure adequate power of at least 0.8.  Additionally, a test 
that excludes the assessment of locomotor activity should be used to examine potential 
anxiety-like behavior.  The startle test employs a device that holds the mouse in a small 
tube and measures the magnitude of response to an auditory stimulus.  This measurement 
of anxiety-like behavior does not employ any locomotion; therefore the startle test may 
be a good experiment for these animals that have a baseline of increased locomotor 
activity.  
Grooming activity appears to be a more complex variable than simply assessing 
frequency and duration of this behavior.  It is suggested that examining the 
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microstructure of grooming could be a better indicator of certain behaviors (Kalueff, 
Aldridge, LaPorte, Murphy, & Tuohimaa, 2007; Smolinsky, Bergner, LaPorte, & 
Kalueff, 2010).  Microstructure includes aspects of method of grooming and partial 
versus complete grooming.  Future experiments could include a more comprehensive 
examination of the microstructure of grooming. 
The experimental paradigm for specific aim three consisted of two weeks of SQ 
DHA injections.  Human studies employ a longer time period of consumption of the n-3 
PUFA’s (Richardson & Puri, 2002; Sinn & Bryan, 2007; Voigt et al., 2001) although it is 
difficult to correlate treatment time in humans compared to treatment time in animals.  It 
could be that the body needs a longer time period for accretion of DHA into the lipid 
bilayer of neuronal cell membranes.  Future experiments will use longer duration of n-3 
PUFA’s as well as different doses to assess the optimal concentration.  The concentration 
of 100mg/kg used in this study was thought to reduce the potential side effect of local 
irritation at the injection site.  It will also be important for future studies to include oral 
consumption of PUFA’s rather than SQ injections.  Additionally, studies have reported 
that prenatal use of n-3 PUFA’s through weaning confers a degree of neuroprotection 
against certain insults to the offspring (Zhang et al., 2010).  Future studies will examine 
the effects of prenatal consumption of DHA (and/or other n-3 PUFA’s) on hyperactive 
locomotor behavior in offspring of mice with the RH mutation.  
It would also be important to examine the effectiveness of a GABAA agonist in 
the treatment of hyperactivity in this model of GEFS+.  Muscimol is a GABAA receptor 
agonist that has been used in multiple studies to examine the effects of various substances 
on GABAA (Del Arco et al., 2011; Pouget, Wattiez, Rivaud-Pchoux, & Gaymard, 2009; 
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Sogaard et al., 2006).  While there are many other GABAA agonists, Muscimol appears to 
be a common agent in animal research.  Using a GABAA agonist may help to elucidate 
the neuronal pathway responsible for hyperactivity in the RH mutant animals.  
It is important to assess how the supplementation of n-3 PUFA’s (whether it is 
given orally or by injection) affect serum and brain levels of fatty acids.  Human studies 
have noted lower levels of fatty acids in the brain in children with ADHD (Colter, Cutler, 
& Meckling, 2008), and animal studies using n-3 deficient diets have reported lower 
brain levels as well as increased locomotor activity (Lavialle et al., 2008; Levant, Radel, 
& Carlson, 2004).  Correlating behavior with brain fatty acid levels would be beneficial 
in possibly linking increased levels with improved behavior.   
We may be able to broaden the results from this study beyond GEFS+ in that 
SCN1A contributes to deficits seen in other disorders.  Screening for genetic variants in 
SCN1A in a population of children with ADHD would also provide further evidence of 
the role of this gene in hyperactive behavior.  
Conclusion 
 In conclusion, perhaps for the first time, findings from this study implicate that 
stress worsens the seizure phenotype in animals with Scn1a mutation recapitulating 
GEFS+.  To our knowledge, this study is also the first to report hyperactive locomotor 
behavior in an animal model of GEFS+.  Further research is needed to replicate findings 
of the effects of acute stress in animal models of GEFS+ as well as examining stress in 
humans with GEFS+.  Additionally, more research is needed regarding the impact of 
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omega 3 PUFA’s on neurological sequelae in this animal model and eventually in the 
human population.  
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APPENDIX A 
PICROTOXIN CODING FORM 
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Mouse #________________ 
Latency to Freezing/Staring (≥ 10 sec)___________ 
0.5) Abnormal Behavior? _____________________ 
1) Latency to 1st Myoclonic Jerk__________ 
Total Number of Jerks_________ 
Time Coded for MJ:  
 Total Time Coded ___________ 
 Minus Time Seizing__________ 
 Minus Latency to MJ_________ 
 Time Coded for MJ__________ 
2) Latency to 1st Focal Seizure___________ 
3) Latency to fully developed bilateral forelimb clonus    ____________ 
3.5) Latency to forelimb clonus with tonic component and twist of the body 
____________ 
4) Latency to GCS with no tonic component _____________ 
4.5) Latency to GTCS w/ FLE________________ 
5) Latency to GTCS w/ FLE & HLE____________ 
5.5) Long-lasting clonus? (yes/no) 
6) Death? (yes/no)__________________________ 
Highest Level on Scale__________ 
Presence of Grooming at the end? (yes/no) 
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APPENDIX B 
PICROTOXIN OBSERVATION FORM 
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Date: 
 
 
 
 
Mouse #: 
 
      
Myoclonic Jerk 
(Starting Time) 
      
Partial (P) or 
Generalized (G) 
Tonic Seizure 
      
GTCS 
(with bouncing) 
      
Hindlimb 
Extension 
      
Status 
Epilepticus (>15 
min) 
      
Death       
Other/Notes: 
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APPENDIX C 
BEHAVIOR GRID 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 140 
 
Date: 
 
 
 
 
 
Behavior      
Grooming 
Duration 
     
Grooming 
Frequency 
     
Scratching      
Rearing      
Stretch-
Attend 
     
Fecal Boli      
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APPENDIX D 
GENOTYPING 
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2 bars equals RH mutant 
1 bar equals WT 
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APPENDIX E 
GSU IACUC APPROVAL FORM 
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APPENDIX F 
GSU IACUC RENEWAL FORM 
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